Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal English Filtered by asset EXPO
Coverage 253,492 Raw stories ingested 39,377 rewritten in CS_CZ • 0 to rewrite (last 7 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 54s ago
  • FMP Forex News Fetch every 5 min 54s ago
  • CoinGecko News Fetch every 5 min 54s ago
  • FIO Stock News Fetch every 10 min 1m ago
  • Patria Stock News Fetch every 10 min 1m ago
  • Editorial rewrite Rewrite every minute 54s ago
  • Asset sync Assets every 1 hour 57m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Clear
Details Date Content Source
2026-10-30 02:25 2d ago
2026-10-29 20:15 2d ago
What Exponent (EXPO) Said on Its Q3 Earnings Call
EXPO Exponent
FMP Stock News
Original source text
7 best fintech ETFs to buy nowExponent NASDAQ: EXPO reported third-quarter 2026 revenue and earnings growth as demand remained strong for its engineering and scientific consulting services, particularly in user research, product safety, failure analysis and dispute-related work.

Total revenue increased 18% year over year to $173.7 million, while net revenue, which excludes reimbursable expenses, rose 12% to $153.1 million. Net income increased 10% to $30.9 million, and diluted earnings per share rose 16% to $0.64 from $0.55 a year earlier.

Get Exponent alerts:

How to Buy OpenAI Stock: A GuideChief Executive Officer Catherine Corrigan said the quarter reflected demand for the company’s specialized expertise as technology becomes more integrated with physical products, infrastructure and human behavior. She cited growth in user research as well as disputes, failure analysis and product-safety work involving chemicals, consumer products and transportation.

Utilization and operating results
Exponent generated third-quarter EBITDA of $45 million, up 16% from the prior-year period. EBITDA margin expanded to 29.4% of net revenue from 28.3% a year earlier.

How to Calculate Moving Average; How it Helps in Stock SelectionBillable hours increased 8% to approximately 405,000, while the company’s average technical full-time-equivalent workforce grew 4% to 1,016 employees. Utilization rose to 76.7% from 74.1%, and the realized billing-rate increase was approximately 4%.

During the call, Chief Financial Officer Eric Anderson said the higher utilization was driven by broad-based demand rather than calendar-related factors. He pointed to dispute-related activity across consumer products, chemicals and transportation, along with stronger-than-expected proactive study work.

A project that represented 4% of revenue in the second quarter declined to 2.5% in the third quarter. Anderson said the company expects that project to represent less than 1% of revenue in the fourth quarter.

Compensation expense, adjusted for deferred-compensation gains and losses, rose 11%. Stock-based compensation increased to $6.7 million from $5.3 million. Other operating expenses rose 9% to $13.8 million, reflecting investments in corporate infrastructure, while general and administrative expense declined 4% to $7.3 million, primarily because the company held a smaller firmwide principals meeting than the prior year’s managers meeting.

Over the past 12 months, Exponent used $171 million for common-stock repurchases, reducing average diluted shares outstanding by 5% to 48.4 million. The company did not repurchase shares during the third quarter. It also distributed $14.7 million through dividends during the quarter.

Segment performance and AI-related demand
The engineering and other scientific segment, which accounted for 85% of net revenue, posted 13% net-revenue growth. The company attributed the increase to user research involving health applications, dynamic real-world environments and sensory perception, as well as disputes concerning chemical facilities, consumer products and advanced transportation technologies.

The environmental and health segment, representing 15% of net revenue, grew 3%. Anderson said growth in that business was supported by projects assessing the effects of chemicals on human health and the environment.

President John Pye said Exponent estimates that artificial intelligence is a direct component of roughly 15% to 20% of its business this year. The company’s AI-related work spans infrastructure supporting AI systems, including data-center components and cooling systems, as well as applications involving data used to train systems and testing of AI performance in real-world conditions.

Pye said clients are increasingly asking Exponent to assess AI-generated recommendations, including recommendations related to materials and formulations, and to investigate why AI systems made certain decisions in vehicles, devices or equipment. He said such projects remain early but are growing.

In response to analyst questions, executives said AI-related reactive work already includes matters involving advanced driver-assistance systems and autonomous vehicles. Executive Vice President Rich Schlenker also cited work on data-center fires, liquid-cooling corrosion, router failures and construction disputes related to AI systems.

Corrigan said medical devices could represent another developing area for AI-related reactive work, particularly as wearable technologies make health-related assessments and decisions.

Hiring priorities and outlook
Management said it is increasing recruiting efforts in response to demand, including university recruiting, lateral hiring from competitors and industry, and hiring from regulatory organizations. Corrigan identified human factors, biomechanics, thermal science, polymers, metallurgy, energy storage, health and environmental expertise as areas of focus.

For the fourth quarter, Exponent expects net revenue growth of 8% to 10% year over year and EBITDA margin of 26.3% to 26.8% of net revenue. Anderson said the outlook assumes utilization of 69% to 70%, which is seasonally lower than the third quarter because of holidays and vacations but consistent with continued robust activity. He noted that the company faces a strong prior-year comparison, when fourth-quarter utilization was 69.2%.

For full-year 2026, Exponent raised its outlook and now expects:

Net revenue growth of 10% to 11%.
EBITDA margin of 28% to 28.3%, compared with 27.6% in 2025.
Average technical employee growth of 4.7% to 5%.
Full-year utilization of 73.5% to 74%, compared with 72.5% in 2025.
Realized rate growth of 3.7% to 4%.
Capital expenditures of $10 million to $12 million.

Management said it plans to continue paying dividends and may repurchase shares during stock-price pullbacks. Anderson said the company also will evaluate potential small acquisitions and other business investments while maintaining its existing capital-allocation approach.

About Exponent (NASDAQ:EXPO)Exponent, Inc is a science and engineering consulting company that helps clients investigate complex technical issues, manage risks, and develop solutions. Its consultants work across disciplines including engineering, materials science, biomechanics, human factors, environmental science, health, data sciences, and economics.

The company provides failure analysis, product safety and testing, accident reconstruction, environmental and health assessments, regulatory support, and expert testimony.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Exponent Right Now?Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
2026-10-30 02:25 2d ago
2026-10-29 21:38 2d ago
Exponent, Inc. (EXPO) Q3 2026 Earnings Call Transcript
EXPO Exponent
FMP Stock News
Original source text
Exponent, Inc. (EXPO) Q3 2026 Earnings Call October 29, 2026 4:30 PM EDT

Company Participants

Catherine Corrigan - CEO & Director
John Pye - President
Eric Anderson - Chief Financial Officer
Richard Schlenker - Executive VP, Corporate Secretary & Director

Conference Call Participants

Joni Konstantelos - Riveron Consulting, LLC
Joshua Chan - UBS Investment Bank, Research Division
Andrew Nicholas - William Blair & Company L.L.C., Research Division
Tobey Sommer - Truist Securities, Inc., Research Division
Tomohiko Sano - JPMorgan Chase & Co, Research Division

Presentation

Operator

Good afternoon, and welcome to the Exponent, Inc. Third Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note, today's event is being recorded. I would now like to turn the conference over to Joni Konstantelos with Investor Relations. Please go ahead.

Joni Konstantelos
Riveron Consulting, LLC

Thank you, operator. Good afternoon, ladies and gentlemen. Thank you for joining us on Exponent's Third Quarter 2026 Financial Results Conference Call. Please note that this call will be simultaneously webcast on the Investor Relations section of the company's corporate website at www.investors.exponent.com. This conference call is the property of Exponent, and any taping or other reproduction is expressly prohibited without prior written consent.

Joining me on the call today are Dr. Catherine Corrigan, Chief Executive Officer; Dr. John Pye, President; Richard Schlenker, Executive Vice President; and Eric Anderson, Chief Financial Officer.

Before we start, I would like to remind you that the following discussion contains forward-looking statements, including, but not limited to, Exponent's market opportunities and future financial results that involve risks and uncertainties that may cause actual results to differ materially from those discussed here. Additional information that could cause actual results to differ from forward-looking statements can be found in Exponent's periodic SEC filings, including those factors discussed under the caption Risk Factor in Exponent's most recent Form 10-Q. The forward-looking statements and risks in this conference
2026-10-29 23:58 2d ago
2026-10-29 17:33 2d ago
Exponent Q3 2026 Earnings Call Transcript
EXPO Exponent
FMP Stock News
Original source text
Exponent (NASDAQ:EXPO) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.

This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation.

Access the full call at https://edge.media-server.com/mmc/p/xqcabu6b/

SummaryExponent Inc reported a strong Q3 2026, with an 18% increase in total revenues to $173.7 million and a 12% rise in net revenues to $153.1 million, driven by demand for engineering and scientific expertise.

Net income grew by 10% to $30.9 million, while diluted earnings per share increased by 16% to $0.64.

The company highlighted significant growth in user research, dispute, failure analysis, and product safety-related work, particularly in the technology, consumer products, chemicals, and transportation sectors.

AI-related work represents 15-20% of the business, with growing demand for AI system evaluations and problem-solving in real-world applications.

Future guidance for Q4 2026 anticipates 8-10% net revenue growth and EBITDA margins of 26.3% to 26.8%. Full-year guidance has been raised to 10-11% net revenue growth and EBITDA margins of 28% to 28.3%.

Exponent is enhancing recruiting efforts to meet increasing demand, particularly in human factors, biomechanics, thermal sciences, and health and environmental fields.

Management emphasized the company’s unique capabilities in addressing complex technological, regulatory, and safety challenges through integrated scientific and engineering expertise.

Full TranscriptOPERATOR

All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today’s presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note today’s event is being recorded. I would now like to turn the conference over to Joni Konsontellos with Investor Relations.

Please go ahead.

Joni Konsontellos (Investor Relations)

Thank you, operator. Good afternoon, ladies and gentlemen. Thank you for joining us on Exponent’s third quarter 2026 financial results conference call. Please note that this call will be simultaneously webcast on the Investor Relations section of the company’s corporate website at www.investors.exponent.com. This conference call is the property of Exponent and any taping or other reproduction is expressly prohibited without prior written consent.

Joining me on the call today are Dr. Katherine Corrigan, Chief Executive Officer, Dr. John Pye, President, Rich Schlenker, Executive Vice President, and Eric Anderson, Chief Financial Officer. Before we start, I would like to remind you that the following discussion contains forward-looking statements, including but not limited to Exponent’s market opportunities and future financial results, that involve risks and uncertainties that may cause actual results to differ materially from those discussed here. Additional information that could cause actual results to differ from forward-looking statements can be found in Exponent’s periodic SEC filings, including those factors discussed under the caption Risk Factors in Exponent’s most recent Form 10-Q. The forward-looking statements and risks in this conference call are based on current expectations as of today and Exponent assumes no obligation to update or revise them, whether as a result of new developments. And now I will turn the call over to Dr. Katherine Corrigan, Chief Executive Officer. Katherine.

Katherine Corrigan (Chief Executive Officer)

Thank you, Joni. And thank you, everyone, for joining us today. I will start off by reviewing our third quarter 2026 business performance. John will then share his perspective on innovation and market trends, and Eric will then provide a more detailed review of our financial results and outlook, and we will then open the call for questions. Before I get into our results, I want to thank those of you who joined us in Phoenix last month for our first Investor Day. We focused that day on a theme that is increasingly central to our business: the convergence of technology, infrastructure, and humans, and the opportunities for Exponent that emerge where they intersect. For those of you who were not able to join us, you can view the non-demonstration portions of the Investor Day on the Investor section of Exponent’s website.

Our goal in Phoenix was not simply to tell you what makes Exponent different, but to bring that differentiation to life and to make it memorable. And in many ways, our third quarter results provide another illustration of that story. Exponent delivered a strong third quarter with double-digit growth in revenues and earnings, reflecting continued demand for our specialized, integrated engineering and scientific expertise. User research continued to be a strong contributor to our growth, and importantly, that work continues to broaden across clients, products, and real-world environments. We also saw growth on top of a strong prior-year quarter in disputes, failure analysis, and product safety-related work across chemicals, consumer products, and transportation.

While these engagements span broad areas of our business, they increasingly reflect the same underlying forces we discussed at our Investor Day. Technology is advancing rapidly, becoming more deeply embedded in physical products and systems, and interacting with people in increasingly complex and consequential ways. We see that convergence particularly clearly in our user research work. As organizations bring new technologies to market, they increasingly need to understand not only whether the technology works, but how it performs when people actually use it in the real world.

That is making our studies both more diverse and more technically complex. Wearable devices, for example, are becoming much more sophisticated. A watch cannot directly measure many of the health variables we care about. Instead, it measures signals that it can directly access at the wrist and increasingly uses sophisticated analytics and machine learning to make predictions about things like cardiovascular health. That raises a much more complex question than whether the sensor itself works: Can those predictions be trusted as a basis for health decisions?

Answering that question requires novel methodologies, benchmarking performance against clinical reference standards, and an understanding of how performance changes across different people and real-world conditions. In consumer electronics, we are increasingly evaluating technology outside of controlled environments. Device users may be riding a bike, or driving a car, or navigating an airport. Our work in sensory perception is also expanding, analyzing how devices communicate information when users are already processing a complex physical environment. These are not simply questions about a device or algorithm. They are questions about the interaction among technology, human behavior, and the physical world.

Answering them takes a broader mix of expertise and requires us to design novel ways to measure both human performance and device behavior, and then interpret the results within the safety, regulatory, and business context our clients face. We see a similar convergence from a different vantage point when products and systems do not perform as intended. During the quarter, we saw increased dispute and failure analysis work across consumer products, chemicals, and transportation. In consumer products, we helped clients assess potential and actual product recalls tied to safety concerns, as expectations from consumers, regulators, and society continue to rise. As the race to embed AI into physical systems accelerates, the interaction among software, hardware, materials, human behavior, and the surrounding environment becomes more complex.

A single product safety investigation, for example, can bring together thermal scientists, mechanical engineers, and materials and polymer experts working together as one team. This is where Exponent’s differentiated position stands out. In transportation, we continue to see increased failure analysis work related to advanced driver assistance systems, another area where sophisticated technology must interact reliably with people and the physical environment. And in chemicals, we saw increased demand for dispute work tied to chemicals of concern, where evolving science, regulation, and societal expectations are creating increasingly complex questions for our clients. Across all these matters, the underlying need is remarkably consistent.

Clients need confidence that increasingly complex products, technologies, and infrastructure will perform safely and reliably in the real world. When they fall short, the consequences of failure are high, and they rely on Exponent for independent, evidence-based analysis and expert judgment that can withstand scrutiny, whether in a courtroom, before a regulator, or in the boardroom. That is why the people and capabilities we highlighted at our Investor Day really matter. We showed you firsthand what sets us apart: our integrated ecosystem of highly talented scientists and engineers, and our ability to bring the right combination of expertise together to solve complex, high-consequence challenges. I would now like to turn it over to our President, John Pye, to share his perspective on how AI is moving into the physical world and where he sees innovation heading across our markets.

John Pye (President)

Thank you, Kathryn. At Investor Day, we described AI as a stack with five layers, starting at the bottom with the electrons that power everything, the chips, the data centers that house them, the models, and at the top, the applications where AI interprets and acts on the physical world. Exponent has work at every layer of this stack. We draw upon our 60 years of science and engineering experience to help our clients extract the highest level of reliability out of supply chains that are under immense stress, delivering traditional products like generators, connectors, cables, even the concrete going into the buildings that make up a data center.

We are also helping those same clients deliver the innovative products that stretch the performance of technology in things like denser network switches and advanced cooling systems. Today, however, most of our AI-related work sits at the top of the stack, in the applications where we deliver the data that trains these systems and where we test how they perform in real-world conditions. In total, we estimate that AI is a direct element of roughly 15 to 20% of our business this year. That figure is an estimate because AI is embedded in so much of the technology our clients build that its influence reaches well beyond those engagements.

What we are seeing today is that questions that were hypothetical a year ago are becoming real projects. Clients using AI to design new materials and formulations are then asking us to evaluate those AI-generated recommendations that raise real safety questions. Others want to understand why an AI system made a particular decision in a vehicle, a device, or a piece of equipment. These engagements are still early, but they are real work, and the inquiries are growing as AI moves into the physical world.

The question is no longer whether it works, but it is what happened, why it happened, and, now more than ever, whether the answer can be trusted. When intelligent products behave unexpectedly, people turn to Exponent for explainability, clarity, and trust. I’ll now turn the call over to Eric to provide more detail on our third quarter results as well as discuss our outlook for the fourth quarter and the full year 2026.

Eric Anderson (Chief Financial Officer)

Thank you, John, and good afternoon, everyone. Let me start by saying all comparisons will be on a year-over-year basis unless otherwise noted. For the third quarter of 2026, total revenues increased 18% to $173.7 million, and revenues before reimbursements, or net revenues as I will refer to them from here on, increased 12% to $153.1 million as compared to the same period of 2025. Total revenues grew faster than net revenues due to a higher level of reimbursable expenses that are included in total revenues. Because reimbursable expenses can fluctuate quarter to quarter based on the mix and nature of client engagements, we believe that net revenue is a more meaningful measure of our underlying performance.

Net income for the third quarter increased 10% to $30.9 million as compared to $28 million during the same period in 2025. Diluted earnings per share increased 16% to $0.64 per share as compared to $0.55 per share during the same period last year. Over the past 12 months, we utilized $171 million for repurchases of our common stock, which resulted in a 5% decrease in our average diluted shares outstanding to 48.4 million shares during the third quarter of 2026 as compared to 51.2 million shares during the same period in 2025.

These repurchases also reduced our interest income. We did not repurchase any of our common stock during the third quarter of 2026. Exponent’s consolidated tax rate was 28% in the third quarter of 2026 compared to 27.4% for the same period in 2025. The tax impact associated with share-based awards was immaterial in both the third quarter of 2026 and 2025. EBITDA for the quarter increased 16% to $45 million, producing a margin of 29.4% of net revenues as compared to $38.8 million, or 28.3% of net revenues, in the same period of 2025.

Billable hours in the third quarter were approximately 405,000, an increase of 8% year over year. Average technical full-time equivalent employees in the third quarter were 1,016, up 4% as compared to one year ago. This increase was a result of our recruiting and retention efforts. Utilization in the third quarter was 76.7%, up from 74.1% in the same period of 2025. The realized rate increase during the third quarter was approximately 4%. In the third quarter, compensation expense, after adjusting for gains and losses in deferred compensation, increased 11%. Included in total compensation expense is a deferred compensation gain of $159,000 as compared to a gain of $7 million in the third quarter of 2025. As a reminder, gains and losses in deferred compensation are offset to miscellaneous income and have no impact on the bottom line. Stock-based compensation expense in the third quarter was $6.7 million as compared to $5.3 million in the prior-year period.

Other operating expenses in the third quarter were up 9% to $13.8 million due to investments in our corporate infrastructure. Included in other operating expenses is depreciation and amortization expense of $2.7 million. G&A expenses decreased 4% to $7.3 million for the third quarter, primarily reflecting lower travel and meal expenses associated with the smaller firmwide principals meeting held during the third quarter of 2026 as compared to the larger managers meeting held during the third quarter of 2025.

Interest income decreased to $668,000 for the third quarter driven by a decrease in cash. Regarding capital allocation during the quarter, capital expenditures were $1.2 million and we distributed $14.7 million to shareholders through dividend payments. Turning to our segments, Exponent’s Engineering and Other Scientific segment represented 85% of net revenues in the third quarter. Net revenues in this segment increased 13%, driven by strong user research activity spanning a broad set of challenges including health applications, dynamic and unstructured real-world environments, and sensory perception, along with dispute-related services involving chemical facilities, consumer products, and advanced transportation technologies.

Exponent’s Environmental Health segment represented 15% of net revenues in the third quarter. Net revenues in this segment increased 3%, driven by increased projects assessing the effects of chemicals on human health and the environment. Turning to our outlook for the fourth quarter of 2026 as compared to one year prior, we expect net revenues to grow 8% to 10% and EBITDA to be 26.3% to 26.8% of net revenues. For the full year of 2026, we are raising our net revenue and margin guidance. We now expect net revenue growth of 10% to 11% and EBITDA to be 28% to 28.3% of net revenues as compared to 27.6% in 2025. We expect our average technical full-time equivalent employees to increase approximately 4% to 5% year over year in the fourth quarter of 2026 and 4.7% to 5% for the full year.

We expect utilization in the fourth quarter to be 69% to 70% as compared to 69% in the same quarter last year. As a reminder, utilization is seasonally lower in the fourth quarter due to more holidays and vacations compared to other quarters. We expect the full-year utilization to be 73.5% to 74% as compared to 72.5% in 2025. We expect the year-over-year realized rate increase to be 3% to 3.5% for the fourth quarter of 2026 and 3.7% to 4% for the full year.

For the fourth quarter, we expect stock-based compensation to be $5.7 million to $5.9 million. For the full year 2026, we expect stock-based compensation to be $28.1 million to $28.4 million. We continue to believe that our stock-based compensation program is a key element to how we effectively attract, motivate, and retain our top talent. For the fourth quarter, we expect other operating expenses to be $13.5 million to $14 million. For the full year, we expect other operating expenses to be $53 million to $53.5 million.

For the fourth quarter, we expect G&A expense to be $7.2 million to $7.7 million, and for the full year we expect G&A expenses to be $28.1 million to $28.6 million. We expect interest income to be $700,000 to $900,000 for the fourth quarter. In addition, we anticipate miscellaneous income to be approximately $300,000. For the remainder of 2026, we do not anticipate any additional tax benefit associated with share-based awards. For the fourth quarter of 2026, we expect our tax rate to be approximately 28% as compared to 27.4% in the same quarter a year ago.

For the full year 2026, the tax rate is expected to be 28.5% as compared to 28% in 2025. Capital expenditures for the full year 2026 are expected to be $10 million to $12 million. We are pleased with the momentum we are carrying into the fourth quarter, and we are well positioned to finish 2026 on a strong note. I will now turn the call back to Katherine for closing remarks.

Katherine Corrigan (Chief Executive Officer)

Thank you, Eric. At Investor Day, we asked you to keep three questions in mind: Why is this market growing? Why does Exponent win? And why can Exponent continue to grow with it? This quarter’s results reinforce the answers to those questions. The market is growing because more is being asked of technology, infrastructure, and the people who depend on them. Artificial intelligence and other digital technologies are moving into the physical world. Demand for power and critical infrastructure is rising, and expectations for safety, reliability, and performance continue to grow. As these worlds converge, our clients’ questions are getting harder, not easier.

And Exponent wins because we are built for hard questions. Our approximately 1,000 consultants, more than 700 of whom hold doctoral degrees, work as an integrated ecosystem across engineering and the sciences. We start with real-world evidence, bring together the expertise each problem requires, and apply independent judgment to deliver conclusions that stand up to scrutiny. And that same complexity gives us confidence in the opportunity ahead. The forces driving demand for our expertise are strengthening. The range of problems our clients bring to us continues to expand. And our investments in talent and capabilities keep us at the leading edge. That is the foundation of our long-term growth framework and our confidence in Exponent’s ability to deliver sustainable long-term value for our shareholders. Operator, we are now ready for questions.

OPERATOR

Thank you. We will now begin the question-and-answer session. To ask a question, you may press star then one on your telephone keypad. If you are using a speakerphone, we ask that you please pick up your handset before pressing the keys. If at any time your question has been addressed and you’d like to withdraw your question, please press star then two. Today’s first question comes from Josh at UBS. Please go ahead. Hello, Josh. Is your line on mute, perhaps?

Josh (Analyst at UBS)

Hi, I’m sorry for that. Thanks for taking my question. I guess utilization was really strong in Q3, even though it’s usually a strong quarter anyways. Is it a function of kind of a structural productivity that you’ve been able to generate, or is there some calendar effects that kind of contribute into the utilization in the quarter?

Eric Anderson (Chief Financial Officer)

Yeah, Josh, this is Eric. It wasn’t really a structural calendar type thing. It was really just broad-based demand across the business. So the third quarter, it’s very few holidays and vacations like we have in the fourth quarter. So that utilization really just reflected, you know, dispute-related services across a broad set of industries, the ones we talk about in the press release—consumer products, chemicals, transportation—and just, you know, good business flow across most areas of our business.

On the proactive side, you know, on the studies, we did a little bit better than expected there. You know, we had talked about a large project that represents 4% of revenues in the second quarter. That project stepped down to 2.5% of revenues in the third quarter. We were expecting it to drop below 2%. So a little bit better than expected there. But that’s really what’s driving it. So it’s not associated with the calendar or holidays, vacations—just the business flow.

Josh (Analyst at UBS)

Okay, okay, that’s helpful. Thank you. And I think you made a comment on the prepared remarks about 15% to 20% of your business being directly related to AI. Now, I was wondering what that percentage would have been like a few years ago, and just kind of curious how the trajectory of this business has been kind of evolving. Thank you.

Katherine Corrigan (Chief Executive Officer)

I’m going to defer to Eric on the few years ago since I’m newer to the seat here. But I can tell you as you look into the future, you talk about the five layers of the stack. All of those layers are growing, Josh. Whether it’s the traditional work where it’s coding or a building catching on fire or an HVAC system not working, or whether it’s the newer stuff as you’re pressing on the technology, all of that is working. And then of course, our user research work that Katherine talked about fits in there too, where we’re delivering the data and helping think about what is the right data to push forward on those new applications.

So looking forward, you see continued growth there and perhaps even some accelerated growth in certain areas. But I’ll defer to Eric on the looking backward piece of what that might.

Eric Anderson (Chief Financial Officer)

Yeah, looking back, Josh, we’ve been doing work in this area for a number of years. So it wasn’t a small number two, three, four, or five years ago. Our work with advanced driver assistance systems and autonomous vehicles—we’ve been doing that for many years. And our risk management work for the utilities, machine learning, you know, that’s also a flow of work that’s been going on for probably the last five to ten years. So I don’t, I don’t have a number to give you.

But it wasn’t something close to zero. You know, we’ve been doing this work and building these capabilities over time.

Josh (Analyst at UBS)

Sure. That makes a lot of sense. And thanks for the color and congrats on the quarter.

Katherine Corrigan (Chief Executive Officer)

Thanks, Josh.

Eric Anderson (Chief Financial Officer)

Thanks, Josh.

OPERATOR

Thank you. And our next question today comes from Andrew Nicholas at William Blair. Please go ahead. Hi, good—

Andrew Nicholas (Analyst at William Blair)

Afternoon. Appreciate you taking my questions. I wanted to circle back to the utilization number in the quarter, I think highest you’ve had for several years, if I’m not mistaken. Curious on kind of how you view that from a headcount growth ambitions perspective or maybe even a pricing perspective. Obviously demand is really good. Your talent is in demand, as are the specialties that you focused on. Just wondering if this is an opportunity to really lean into the higher end of your kind of headcount growth aspirations or maybe lean a little bit further into pricing in ’27.

Any comments on kind of the interplay of utilization and pricing and headcount growth would be great.

Katherine Corrigan (Chief Executive Officer)

Yeah. Thank you, Andrew. And I think you’ve really hit the nail on the head. I mean, you can see the demand that is pushing on the business and you see that in the utilization and that’s very typically the first place where it shows up. But we are, what we say about the drivers is not a short term thing. Right. We see the demand drivers continuing to be strong and so we’re absolutely pushing that recruiting effort, those hiring efforts. We always want to balance the headcount growth with the demand.

In a perfect world, you sort of bring them along perfectly calibrated together. But look, our practices and our teams are very motivated to hire right now, as you might imagine. They are very busy and they see even more opportunity on the horizon. So it does give us an opportunity to say, hey, as we go into planning and as we’re doing now, we’re bringing the people in for the interviews. We’re out at the schools, especially in the fall recruiting season. This is a very important time of year for, for us when we talk about our university recruiting.

You know, we are looking at lateral type of hires from competitors, from industry, from the regulators. And so it’s really all those facets of our, of our recruiting strategy. We are, you know, we have turned up the dials on those and so are working to, you know, sort of balance those things. And I think, look, we’re still heading into the, you know, we’re in the midst of the planning process. We will obviously have more to say about things like pricing and, and specific headcount growth. But those are things that we are working very hard with our different business units on and look forward to sharing with you in another quarter.

Andrew Nicholas (Analyst at William Blair)

Very helpful, thank you. And then I was hoping you could maybe break out the growth between proactive and reactive in the quarter, at least at a high level quantitatively. I think as you mentioned in the release, it was a pretty tough compare, reactive in particular. So any color on how both of those parts of your business grew would be helpful. Thank you.

Eric Anderson (Chief Financial Officer)

Yep, I can give you a little color on that. So on the proactive side, it grew in the, call it the high teens, and the reactive side in the high single digits. And like you said, and like Katherine said in prepared remarks, that number on the reactive side was on top of a very strong quarter in Q3 of last year.

Katherine Corrigan (Chief Executive Officer)

Yeah. And I would add, Andrew, you know, the reactive work, the disputes work, it’s not a scenario where we had sort of one big project or two big projects. It really was kind of diversified across a number of these different areas and seeing that strong utilization in our disputes folks.

Andrew Nicholas (Analyst at William Blair)

Thank you very much.

OPERATOR

Thank you. Our next question today comes from Toby Sommer at Truist. Please go ahead.

Toby Sommer (Analyst at Truist)

Thanks. I want to start with just a small tactical question. The 4% project that went to two and a half, what’s the assumption in 4Q for the contribution from that project?

Eric Anderson (Chief Financial Officer)

Yeah, Toby, that project we expect to wind down to under 1% of revenues in the fourth quarter. So it’s not a big part of our forecast.

Toby Sommer (Analyst at Truist)

Sure, I appreciate that. Thank you. I wanted to ask a question about AI. Specific work in reactive engagements that look like at the investor day it sounded like more opportunity currently exists in early. We heard more examples about sort of proactive opportunities. But on the reactive side, as AI breaks something in the physical world and causes damages and creates exposures, is that already out there in the market? Is that something you’re involved in or is that a prospective opportunity?

John Pye (President)

Hey Toby, this is John. No, I think AI has been in products in one shape or form for several years now. You saw it probably most early in the transportation industry as you started getting into advanced driver assistance systems and then in automated vehicles. And there’s a large portion of what we do in that industry that is reactive. And so what did the machine do? When did it see what it was supposed to see? Did it do the right thing upon seeing that, did it turn right or left as Kathryn always is fond of saying in her examples.

That part of the work is not a future-looking expectation, that’s here right now. And then as AI makes it into other areas where decisions are being made and there’s safety consequences. The example I gave around chemical formulations and things like that, those are examples that are happening right now. Have they moved into the litigation stage where there’s a dispute around them? Well, that’s maybe a little bit early, but you can continue to see the pace of that moving forward.

Katherine Corrigan (Chief Executive Officer)

Yeah, and I would just add the next place where we’re starting to see more is going to be the medical device arena. When you think about that wearable or that technology that’s giving a health-related decision, that is not at the level of the advanced driver assistance piece that John was talking about. But that’s kind of as I see it, on the reactive side, maybe the next kind of sort of ramp that we have to think about.

Rich Schlenker (Executive Vice President)

Yeah, Toby, this is Rich, just a little bit to add here. That’s really the related part that we’ve been talking of traditional parts of the AI stack which are that we are already seeing construction disputes related to AI systems. We are already working on significant events that have occurred, fires. And at data centers around the world we are being called in to help clients on failure analysis of components. So that’s everything from corrosion related to liquid cooling systems.

It is failures of routers. Those have really been helping people at that level just get over the hump and push the thing aside and, and get the feedback into their vendors. History tells us eventually those end up with, when people slow down a little, they end up with the dispute between the supplier and the OEM that needs to be worked out as a, you know, where the finances get paid for those corrections. We saw that across almost every automotive manufacturer in the electric vehicle area.

Every one of them had product recalls around the battery systems that were out there, eventually worked through it. Many of them ended up having to work things out financially with their suppliers related to that. So these are the things that are in the early days that are building up, but they’re all the things that we’ve been working on, as John said, for 16 years.

Toby Sommer (Analyst at Truist)

Is there much of a track record of examples of reactive projects where the actual AI firms developing the models and new models, as those models sometimes go rogue or do something unintended? Is that kind of stuff percolating in the judicial system or in the regulatory environment?

Rich Schlenker (Executive Vice President)

Well, I mean it’s every news article you read these days. And that makes it certainly through the regulatory side as you try to figure out where it’s going and ultimately into the disputes world. I think it shows up in all of those things, Toby. Our exposure to that is I think more on the earlier stages rather than in the dispute that will ultimately come up when the AI shuts down your travel reservation system or the cybersecurity is maybe not where you wanted it to and something happens there.

But I think that’s just a matter of time how it works its way into a more significant portion of our workflow. And I think, look, the perfect example, which Exponent has been executing on here for a number of years but is now cases that are related to fully autonomous is in the vehicle area. This is where these systems have come in. There is actual product liability suits. There are actual regulatory investigations into each of these questions of why the vehicle didn’t stop or why did the, you know, the Cruise vehicle make the decision it made nearly two years ago in San Francisco.

Those are the questions Exponent’s being asked to answer. We’ve written the reports that are public in some of these matters. Others are maybe a litigation matter and might not be out there, but some of these are out there in the public. So that is what’s happened in that environment. It will play out across the rest of the products areas over time.

Toby Sommer (Analyst at Truist)

Thank you. You’ve been generous with your time. I’d like to ask one more. In your hiring outlook, what other areas of the business or practices or even scientific specialties do you expect to hire the most in?

Katherine Corrigan (Chief Executive Officer)

Yeah, I can jump in on that. Look, it’s a lot of different areas. Human factors is one example. When you think about the human-machine interface and that convergence that we’ve been talking about, that’s going to pull in your human factors, it’s pulling in your biomechanics as well. When you think about the data center infrastructure side of what’s going on and also the energy side of the market drivers for us there, you’re talking about your thermal scientists, you’re talking about your polymer folks, you’re talking about your metallurgists, you’re also talking about people with energy storage type of experience.

And look, we also have to think about that health and environmental side. You know, this has been a place where we have invested in senior talent and we will continue to do that. When you think about things like PFAS, you think about other emerging chemicals and you know, those are places where we not only are hiring in health and environmental, but we’re hiring on the engineering side and the material side, because it’s those questions of, you know, where are the replacements for these materials and why are they useful in products are the kinds of questions that are arising.

So, you know, those are some of the examples of places where, you know, when we’re at the universities, we’re looking at the different laboratories, the different departments where we’re very focused.

Toby Sommer (Analyst at Truist)

Thank you.

OPERATOR

Thank you. And our next question today comes from Tomo Sano at JPMorgan. Please go ahead.

Tomo Sano (Analyst at JPMorgan)

Hi, good afternoon everyone. Thank you. Maybe on the Q4 outlook, you’re guiding to 8% to 10% growth versus 4% in Q3, despite the easier year-over-year comps. Could you talk about what’s driving that moderation? Is it project timing or are there any areas where you see assuming some slowing in demand?

Eric Anderson (Chief Financial Officer)

Yeah, Tomo, it’s not on a sequential basis. It’s not really moderating. So we guided to 69% to 70% utilization. Josh earlier asked a question about the holidays and vacations or the structural part of that. That 69% to 70% utilization in the fourth quarter is roughly equivalent to the 77% that we just did in the third quarter. So we’re expecting this, you know, robust level of activity to continue into the fourth quarter. When I look back at the fourth quarter last year, that was also a very busy quarter, you know, 69.2% utilization, the fourth quarter strong.

So we’ve got a tough comparable is why you’re seeing that at 8% to 10%, you know, versus low double digits like we just did in the third quarter.

Tomo Sano (Analyst at JPMorgan)

Okay, thank you. And if you could talk about environmental and health, that was actually up 3%, well below engineering and then scientific. What would you say need to change for the growth in that segment to reaccelerate? And are you seeing any signs of that today?

Katherine Corrigan (Chief Executive Officer)

Yeah, thanks, Tomo. And I was alluding to that a little bit in my comments just a minute ago. You know, this is a place where we are very focused on recruiting, and in particular senior recruiting. We’ve brought on some principal-level folks in the last 12 to 18 months. They continue to ramp and we continue to make those investments. So that’s a key element of making sure that we can see sustainable growth over time. Because what you can then do when you have those principals is you are building additional teams underneath them.

You’re able to expand your capabilities, maybe across different emerging chemicals and different issues, both on the reactive and the proactive side. And look, this business very much splits across those two pieces, right? We have the dispute-related work around chemicals in the environment, but there’s also the proactive regulatory piece of that business. And that is a place where, again, we continue to seed with hires. You know, we are taking those out of regulators, for example, and we continue to work with clients on what their latest technologies are. So it’s a, you know, look, it’s about building the capability, envisioning what the emerging trends are, and positioning ourselves with the talent to then capture that work.

Tomo Sano (Analyst at JPMorgan)

Thank you, Katherine. And if I can squeeze just one more on capital allocations. So you repurchased about $146 million of the stock year-to-date. How are you thinking about the pace of buybacks from here versus preserving capital for investment or M&A?

Eric Anderson (Chief Financial Officer)

Yeah, our philosophy on that hasn’t changed. You know, we are going to continue to pay a dividend. We’re going to buy back shares when there’s pullbacks in the stock price like we did during the first half of this year. We’ve still got that $50 million that the board authorized for share repurchases. So going forward, our, you know, our philosophy is not going to change. We’re obviously going to evaluate opportunities for maybe a small acquisition here or there and other, you know, investments that we can make into the business and deploy cash, you know, consistent with how we have in the past.

Tomo Sano (Analyst at JPMorgan)

Right. Thank you, Eric. That’s all from me.

Katherine Corrigan (Chief Executive Officer)

Thanks so much.

OPERATOR

Thanks, everyone. That concludes today’s question and answer session and today’s conference call. We thank you all for attending today’s presentation. You may now disconnect your lines and have a wonderful day.

Disclaimer: This transcript is provided for informational purposes only. While we strive for accuracy, there may be errors or omissions in this automated transcription. For official company statements and financial information, please refer to the company’s SEC filings and official press releases. Corporate participants’ and analysts’ statements reflect their views as of the date of this call and are subject to change without notice.

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
2026-10-29 23:58 2d ago
2026-10-29 18:36 2d ago
Exponent (EXPO) Tops Q3 Earnings and Revenue Estimates
EXPO Exponent
FMP Stock News
Original source text
Exponent (EXPO - Free Report) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.55 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +6.67%. A quarter ago, it was expected that this engineering and scientific consulting company would post earnings of $0.55 per share when it actually produced earnings of $0.6, delivering a surprise of +9.09%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Exponent, which belongs to the Zacks Consulting Services industry, posted revenues of $153.06 million for the quarter ended September 2026, surpassing the Zacks Consensus Estimate by 2.72%. This compares to year-ago revenues of $137.07 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Exponent shares have added about 11% since the beginning of the year versus the S&P 500's gain of 13.1%.

What's Next for Exponent?While Exponent has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Exponent was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.51 on $139.04 million in revenues for the coming quarter and $2.31 on $588.74 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Consulting Services is currently in the top 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, CRA International (CRAI - Free Report) , is yet to report results for the quarter ended September 2026. The results are expected to be released on November 5.

This consulting firm is expected to post quarterly earnings of $2.06 per share in its upcoming report, which represents no change from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

CRA International's revenues are expected to be $198.64 million, up 6.9% from the year-ago quarter.
2026-10-29 21:28 2d ago
2026-10-29 16:05 2d ago
Exponent Declares Regular Quarterly Dividend for Q4 2026
EXPO Exponent
FMP Stock News
Original source text
 | Source: Exponent, Inc.

MENLO PARK, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.31 per share of common stock to be paid on December 18, 2026 to all common stockholders of record as of December 4, 2026.

Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent’s Board of Directors.

“Our quarterly cash dividend reflects the consistency of Exponent’s cash generation and our continued commitment to returning capital to shareholders,” commented Dr. Catherine Corrigan, Chief Executive Officer. “Our disciplined approach to capital allocation, supported by a strong balance sheet, allows us to return capital to shareholders while continuing to invest in the people and capabilities that drive long-term growth.”

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.

Exponent may be reached at (888) 656­-EXPO, [email protected], or www.exponent.com.

Forward Looking Statements

This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.
2026-10-29 21:28 2d ago
2026-10-29 16:05 2d ago
Exponent Reports Third Quarter 2026 Financial Results
EXPO Exponent
FMP Stock News
Original source text
MENLO PARK, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2026 ended October 2, 2026.

“Exponent delivered another strong quarter, with double-digit growth in revenues and earnings, reflecting continued demand for our specialized, integrated engineering and scientific expertise,” stated Dr. Catherine Corrigan, Chief Executive Officer. “User research studies continued to be a strong contributor to our growth, as clients move quickly to understand how people interact with technology across a widening range of devices and applications. Reactive work also grew, on top of a strong prior-year quarter, with increased dispute-related and failure analysis demand in the chemical, consumer products and transportation industries.

“These results reflect the durable, long-term trends shaping our business, including rapid technological innovation, increasing complexity, investment in critical infrastructure, and rising societal expectations for safety and reliability. As artificial intelligence and other digital technologies become increasingly embedded into physical systems, the digital and physical worlds are converging. Exponent is differentiated at that convergence, where data and computation meet real-world evidence, and where technology must ultimately work for the user. Our multidisciplinary scientists and engineers bring together deep domain expertise, scientific rigor, and an understanding of complex physical systems to help clients innovate with confidence, solve their most challenging problems, and manage high-consequence risk,” Dr. Corrigan continued.

Third Quarter Financial Results

Total revenues and revenues before reimbursements for the third quarter of 2026 increased 18% to $173.7 million and 12% to $153.1 million, respectively, as compared to $147.1 million and $137.1 million in the third quarter of 2025.

Net income increased to $30.9 million, or $0.64 per diluted share, in the third quarter of 2026, as compared to $28.0 million, or $0.55 per diluted share, in the same period of 2025. The tax benefit associated with share-based awards was immaterial in both the third quarter of 2026 and 2025. Inclusive of the tax benefit, Exponent’s consolidated tax rate was 28.0% in the third quarter of 2026, as compared to 27.4% for the same period in 2025.

EBITDA1 increased to $45.0 million, or 29.4% of revenues before reimbursements, in the third quarter of 2026, as compared to $38.8 million, or 28.3% of revenues before reimbursements in the third quarter of 2025.

Year to Date Financial Results

Total revenues and revenues before reimbursements for the first three quarters of 2026 increased 18% to $511.6 million and 11% to $453.7 million, respectively, as compared to $434.6 million and $407.4 million in the same period of 2025.

Net income increased to $89.9 million, or $1.83 per diluted share, through the first three quarters of 2026, as compared to $81.2 million, or $1.58 per diluted share, in the same period of 2025. During the first three quarters of 2026, we realized a negative tax impact associated with share-based awards of $0.8 million, as compared to $0.4 million during the same period one year ago. Inclusive of the tax impact associated with share-based awards, Exponent’s consolidated tax rate was 28.7% through the first three quarters of 2026, as compared to 28.2% for the same period last year.

EBITDA1 increased to $130.8 million, or 28.8% of revenues before reimbursements, through the first three quarters of 2026, as compared to $113.4 million, or 27.8% of revenues before reimbursements, in the same period of 2025.

Through the first three quarters of 2026, Exponent paid $46.1 million in dividends, repurchased $146.1 million of common stock, and closed the period with $114.7 million in cash and cash equivalents.  

In a separate press release today, Exponent announced its quarterly cash dividend of $0.31 to be paid on December 18, 2026, and reiterated its intent to continue to pay quarterly dividends.

Business Overview

Exponent’s engineering and other scientific segment represented 85% of the Company’s revenues before reimbursements in the third quarter and through the first three quarters of 2026. Revenues before reimbursements in this segment increased 13% in the third quarter and through the first three quarters of 2026, as compared to the prior year period. Growth during the quarter was driven by strong user research activity spanning a broad set of challenges, including health applications, dynamic and unstructured real-world environments, and sensory perception. Dispute-related services involving chemical facilities, consumer products and advanced transportation technologies also drove growth in the quarter, as clients rely on Exponent in critical, high-stakes situations.

Exponent’s environmental and health segment represented 15% of the Company’s revenues before reimbursements in the third quarter and through the first three quarters of 2026. Revenues before reimbursements in this segment increased 3% in the third quarter and 4% through the first three quarters of 2026, as compared to the prior year period. Growth in this segment was driven by increased projects assessing the effects of chemicals on human health and the environment.

Business Outlook

“Our ability to scale our operating model in response to market demand resulted in 77% utilization and expanded profitability during the third quarter of 2026. We are encouraged by the market opportunities across the industries we serve and continue to strategically build upon our diversified portfolio of talent and capabilities,” commented Eric Anderson, Chief Financial Officer. “As we close out 2026, we are raising our full-year revenue and margin guidance, reflecting the strength of our year-to-date performance and our outlook for the remainder of the year. Looking ahead, we remain confident in Exponent’s long-term growth trajectory and our ability to capitalize on the strong demand for our differentiated expertise.”

For the fourth quarter of fiscal 2026 as compared to the same period one year prior, Exponent anticipates:

Revenues before reimbursements to grow 8% to 10%; and,EBITDA1 to be 26.3% to 26.8% of revenues before reimbursements. For the full fiscal year 2026 as compared to fiscal year 2025, Exponent anticipates:

Revenues before reimbursements to grow 10% to 11%; and,EBITDA1 to be 28.0% to 28.3% of revenues before reimbursements. “Rapid innovation continues to reshape industries as companies race to make physical products more intelligent, while expectations for safety, reliability, and performance continue to rise. Exponent is built for this moment. We help clients navigate these increasingly complex challenges, whether validating AI-enabled systems, strengthening critical infrastructure, or understanding how people interact with the technologies around them. Across these areas, our integrated platform brings the scientific and engineering expertise needed to deliver explainability, clarity, and trust. This distinctive ecosystem, together with strong long-term growth drivers, positions Exponent to deliver sustainable value for our clients and shareholders,” concluded Dr. Corrigan.

Today's Conference Call Information

Exponent will discuss its financial results in more detail on a conference call today, Thursday, October 29, 2026, starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. The audio of the conference call is available by dialing (844) 481-2781 or (412) 317-0672. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent website, or by dialing (855) 669-9658 or (412) 317-0088 and entering passcode 5957331#.

Use of non-GAAP Financial Measures 1

EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation, and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income, and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present, and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position, or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.

Exponent has provided its outlook regarding EBITDA as a percentage of revenues before reimbursements. The Company has not reconciled this non-GAAP financial measure to the corresponding GAAP financial measure because guidance for the various reconciling items is not provided and the Company is unable to estimate with reasonable certainty the effect of these items without unreasonable effort. For example, the Company is unable to estimate with reasonable certainty the impact of equity awards on Exponent’s taxes without unreasonable effort. These items are uncertain, depend on various factors, and may have a material effect on Exponent’s results computed in accordance with GAAP. A reconciliation between the historical GAAP and non-GAAP financial measures presented in this release is provided in the financial tables at the end of this release.

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.

Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.

Forward Looking Statements

This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

Source: Exponent, Inc.

EXPONENT, INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME For the Quarters Ended October 2, 2026 and October 3, 2025 (unaudited) (in thousands, except per share data)                                  Quarter Ended Nine Months Ended        October 2, October 3, October 2, October 3,        2026
 2025
 2026
 2025
                Revenues             Revenues before reimbursements $153,063 $137,073 $453,740 $407,378  Reimbursements    20,670  10,047  57,908  27,211                  Revenues    173,733  147,120  511,648  434,589                Operating expenses            Compensation and related expenses  90,038  87,726  282,018  261,103  Other operating expenses   13,814  12,655  39,504  36,822  Reimbursable expenses   20,670  10,047  57,908  27,211  General and administrative expenses  7,334  7,654  20,940  18,806         131,856  118,082  400,370  343,942                  Operating income   41,877  29,038  111,278  90,647                Other income (expense), net           Interest income, net   668  2,312  3,102  7,370  Miscellaneous income (expense), net  448  7,267  11,718  15,175         1,116  9,579  14,820  22,545                  Income before income taxes  42,993  38,617  126,098  113,192                Income taxes     12,050  10,573  36,191  31,945                  Net income   $30,943 $28,044 $89,907 $81,247                               Net income per share:           Basic    $0.64 $0.55 $1.84 $1.59  Diluted    $0.64 $0.55 $1.83 $1.58                Shares used in per share computations:          Basic     48,131  50,872  48,891  51,113  Diluted     48,422  51,179  49,195  51,454                 EXPONENT, INC. CONDENSED CONSOLIDATED BALANCE SHEETS October 2, 2026 and January 2, 2026 (unaudited) (in thousands)                                October 2, January 2,          2026   2026      Assets       Current assets:
         Cash and cash equivalents  $114,689  $221,930    Accounts receivable, net   209,604   181,507    Prepaid expenses and other assets  28,976   24,143     Total current assets   353,269   427,580   Property, equipment and leasehold improvements, net  69,900   71,981   Operating lease right-of-use asset  68,208   73,376   Goodwill
    8,607   8,607   Other assets
    193,092   195,975          $693,076  $777,519                  Liabilities and Stockholders' Equity      Current liabilities:         Accounts payable and accrued liabilities $34,733  $30,942    Accrued payroll and employee benefits  121,993   121,302    Deferred revenues    18,503   18,868    Operating lease liability   6,533   6,890     Total current liabilities  181,762   178,002   Other liabilities
    128,822   133,232   Operating lease liability   74,606   75,944     Total liabilities   385,190   387,178               Stockholders' equity:         Common stock    66   66    Additional paid-in capital   392,784   369,747    Accumulated other comprehensive loss  (2,496)  (2,290)   Retained earnings    712,318   668,423    Treasury stock, at cost   (794,786)  (645,605)     Total stockholders' equity  307,886   390,341          $693,076  $777,519                EXPONENT, INC.EBITDA and EBITDAS (1)For the Quarters Ended October 2, 2026 and October 3, 2025(unaudited)(in thousands)                               Quarter Ended Nine Months Ended       October 2, October 3, October 2, October 3,        2026   2025   2026   2025               Net Income    $30,943  $28,044  $89,907  $81,247               Add back (subtract):                         Income taxes    12,050   10,573   36,191   31,945  Interest income, net   (668)  (2,312)  (3,102)  (7,370) Depreciation and amortization  2,651   2,532   7,844   7,544                 EBITDA (1)    44,976   38,837   130,840   113,366                Stock-based compensation   6,694   5,341   22,432   18,767                 EBITDAS (1)  $51,670  $44,178  $153,272  $132,133                                           (1) EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.
2026-10-19 16:08 12d ago
2026-10-19 10:41 12d ago
Is Exponent (EXPO) Stock Outpacing Its Business Services Peers This Year?
EXPO Exponent
FMP Stock News
Original source text
The Business Services group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Exponent (EXPO - Free Report) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.

Exponent is a member of our Business Services group, which includes 244 different companies and currently sits at #6 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Exponent is currently sporting a Zacks Rank of #2 (Buy).

The Zacks Consensus Estimate for EXPO's full-year earnings has moved 1.1% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

According to our latest data, EXPO has moved about 3.4% on a year-to-date basis. At the same time, Business Services stocks have lost an average of 10.3%. This means that Exponent is outperforming the sector as a whole this year.

Another stock in the Business Services sector, NTT (NTTYY - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 9.8%.

The consensus estimate for NTT's current year EPS has increased 9.9% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).

Looking more specifically, Exponent belongs to the Consulting Services industry, a group that includes 13 individual stocks and currently sits at #66 in the Zacks Industry Rank. This group has lost an average of 19.3% so far this year, so EXPO is performing better in this area.

NTT, however, belongs to the Technology Services industry. Currently, this 123-stock industry is ranked #85. The industry has moved -21.5% so far this year.

Going forward, investors interested in Business Services stocks should continue to pay close attention to Exponent and NTT as they could maintain their solid performance.
2026-10-05 10:26 26d ago
2026-10-05 03:05 27d ago
Corient Private Wealth LP Trims Stake in Exponent, Inc. $EXPO
EXPO Exponent
FMP Stock News
Original source text
Corient Private Wealth LP lessened its holdings in Exponent, Inc. (NASDAQ:EXPO – Free Report) by 81.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,463 shares of the business services provider’s stock after selling 19,282 shares during the quarter. Corient Private Wealth LP’s holdings in Exponent were worth $262,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in EXPO. Nykredit A S bought a new position in shares of Exponent in the 2nd quarter worth about $202,000. Susquehanna International Group LLP boosted its stake in Exponent by 42.9% in the second quarter. Susquehanna International Group LLP now owns 75,694 shares of the business services provider’s stock valued at $4,448,000 after acquiring an additional 22,733 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Exponent by 160.5% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 271,842 shares of the business services provider’s stock valued at $15,973,000 after purchasing an additional 167,484 shares during the last quarter. Empowered Funds LLC bought a new position in shares of Exponent during the second quarter valued at approximately $558,000. Finally, Jefferies Financial Group Inc. acquired a new stake in shares of Exponent during the 2nd quarter worth approximately $3,928,000. Institutional investors own 92.37% of the company’s stock.

Insiders Place Their Bets In related news, CEO Catherine Corrigan sold 1,707 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $66.28, for a total value of $113,139.96. Following the completion of the sale, the chief executive officer owned 129,108 shares of the company’s stock, valued at $8,557,278.24. This represents a 1.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is owned by insiders.

Analysts Set New Price Targets Several analysts recently issued reports on EXPO shares. JPMorgan Chase & Co. raised their price target on Exponent from $80.00 to $90.00 and gave the stock an “overweight” rating in a report on Friday, July 31st. UBS Group set a $72.00 target price on Exponent and gave the stock a “neutral” rating in a research report on Friday, July 31st. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Exponent in a research note on Friday, July 17th. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $81.00. Check Out Our Latest Research Report on EXPO

Exponent Stock Performance Shares of NASDAQ EXPO opened at $67.30 on Monday. Exponent, Inc. has a 12-month low of $51.91 and a 12-month high of $81.95. The company has a market cap of $3.20 billion, a PE ratio of 30.18 and a beta of 0.69. The stock has a 50 day simple moving average of $67.70 and a 200-day simple moving average of $63.88.

Exponent (NASDAQ:EXPO – Get Free Report) last posted its earnings results on Thursday, July 30th. The business services provider reported $0.60 EPS for the quarter, beating the consensus estimate of $0.55 by $0.05. Exponent had a return on equity of 31.48% and a net margin of 17.67%.The firm had revenue of $171.61 million for the quarter, compared to analysts’ expectations of $144.99 million. During the same period last year, the firm earned $0.52 EPS. The firm’s revenue was up 12.0% compared to the same quarter last year. Sell-side analysts forecast that Exponent, Inc. will post 2.31 earnings per share for the current fiscal year.

Exponent Dividend Announcement The business also recently disclosed a quarterly dividend, which was paid on Friday, September 18th. Investors of record on Friday, September 4th were paid a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date was Friday, September 4th. Exponent’s payout ratio is currently 55.61%.

About Exponent (Free Report)

Exponent, Inc is an engineering and scientific consulting company that helps clients investigate complex technical issues, manage risk, and improve the safety and performance of products, systems, and structures. Its multidisciplinary consulting services support legal, insurance, industrial, government, and other organizational clients.

The company’s services include failure analysis, accident reconstruction, product safety and testing, materials and corrosion analysis, environmental and human health assessments, biomechanics, human factors, electrical and electronic systems analysis, civil and structural engineering, and data sciences.

Recommended Stories Five stocks we like better than Exponent Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-02 01:40 30d ago
2026-10-01 21:30 30d ago
Ballard launches Fleet360 services for new North American FCmove®-HD+ fleets at APTA EXPO 2026
EXPO Exponent
FMP Stock News
Original source text
End-to-end service program combines fuel cell module performance guarantee with committed service response and resolution times, to enable transit operators to plan maintenance and fuel cell lifecycle costs.

, /PRNewswire/ -- Ballard Power Systems is launching the first-of-its-kind fuel cell lifecycle programme – Ballard Fleet360 – at APTA TRANSform & EXPO 2026 in Chicago.

Available with new FCmove®-HD+ module sales in North America, the program connects intelligent fuel cell data, tailored technical support, parts assurance, technician training and refurbishment options. Fleet360's FCcare+ coverage package provides a fuel cell module performance guarantee for power output up to 250,000 miles of fuel cell operation.

Ballard Fleet360 fuel cell lifecycle program "Transit operators want confidence in how their fuel cells perform today and as their fleets age," said Ralph Robinett, Chief Operating Officer of Ballard. "With Fleet360, we are backing our technology with a defined performance guarantee, supported by the information, parts and technical support maintenance teams need. This capability gives customers a clearer basis for planning fuel cell maintenance and lifecycle budgets, with performance commitments from Ballard."

Turning fuel cell data into maintenance decisions

At the center of Fleet360 is FCpulse, Ballard's digital platform for visibility into fuel cell health, performance and service-part trends. Its state of health dashboard helps maintenance teams proactively identify modules needing attention, prioritise investigations and prepare workshop resources. Its data visualizer access supports deeper technical investigation, while quarterly performance reports inform service and lifecycle planning.

Defined guarantees for module performance

The FCcare service package combines full parts coverage with commitments for response, spare part delivery and resolution, alongside FCpulse state of health dashboard access. The FCcare+ package adds a fuel cell module performance guarantee for power output power up to 250,000 miles of fuel cell operation. Guarantees and service commitments are defined by the package and agreement selected. Core+ refurbishment, Ballard Academy training and the full version of FCpulse are available alongside either package.

Service support built around fleet operations

The program is supported by Ballard's Remote Operations Centre in Vancouver, which coordinates triage, diagnostics and engineering escalation, together with expanded field service capability and US parts inventory in Bend, Oregon. The Ballard Academy builds customers' in-house maintenance capability and diagnostic skills, while Core+ connects stack condition assessment with refurbishment planning.

"Data creates value when it helps a maintenance team decide what to do next," Robinett added. "By connecting FCpulse insights with parts support, technical expertise and refurbishment planning, we can help operators prepare for maintenance and budget for the fuel cell module over its life. Our role is to give their teams the information and practical support to make those decisions with greater confidence."

Fleet360 builds on Ballard's experience across more than 186 million miles (300 million kilometers) of operational service and more than 3,000 fuel cell engines on the road. Today, Ballard has deployed nearly 330 fuel cell buses across North America, including over 225 buses in California and a fleet of more than 30 in Nevada.

Together, the market-leading FCmove® range of fuel cell engines and Ballard Fleet360 demonstrate Ballard's focus on the complete customer journey – from vehicle integration and deployment to reliable operation throughout the fleet lifecycle.

Ballard's presence at APTA EXPO 2026 also comes just weeks after the completion of its acquisition of GeoPura. The acquisition broadens Ballard's capabilities beyond fuel cell engines to include hydrogen production, logistics, refueling, and integrated Energy-as-a-Service solutions. These expanded capabilities strengthen Ballard's ability to support customers with the technology, services, and hydrogen solutions needed to deploy and operate zero-emission fleets at scale.

Meet Ballard at APTA EXPO 2026

Transit operators and bus manufacturers can meet Ballard's team at APTA EXPO 2026 to discuss Fleet360 coverage and service options. Visit us at Booth 462 from October 5-7.

About Ballard

Ballard Power Systems (NASDAQ: BLDP; TSX: BLDP) is a global leader in zero-emission hydrogen energy solutions and an integrated Energy-as-a-Service (EaaS) provider. Together, with its wholly owned subsidiary, GeoPura Ltd., Ballard delivers turnkey, vertically integrated hydrogen ecosystem solutions spanning hydrogen production, logistics, refuelling, zero-emission fuel cell engines, and stationary Hydrogen Power Units.

Ballard powers critical off-grid, stationary applications - including construction, events, film sets, healthcare, defense, temporary power infrastructure, and supplies fuel cell engines for heavy-duty mobility applications such as bus, rail, and marine. With an EaaS model, combined with cutting-edge technology across the hydrogen value chain, Ballard decarbonizes mission-critical operations worldwide. To learn more about Ballard, visit www.ballard.com.

Further Information

Sumit Kundu – Investor Relations, +1.604.360.3517 or [email protected]

SOURCE Ballard Power Systems Inc.
2026-09-30 03:10 1mo ago
2026-09-29 22:00 1mo ago
Exponent Hosts Investor Day
EXPO Exponent
FMP Stock News
Original source text
Event showcased the multidisciplinary science and engineering behind its growth  | Source: Exponent, Inc.

MENLO PARK, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today hosted an Investor Day at its Phoenix Test and Engineering Center.

Presentations by Exponent’s leadership team and key market leaders highlighted the forces driving the business and the Company’s growth opportunities, including the rise of artificial intelligence and data center infrastructure, escalating risk in the energy and utility sector, and the growing focus on chemicals of concern. The event also included live demonstrations of Exponent’s research and testing capabilities across human factors, user research, energy storage, robotics, and transportation applications.

“Today, our guests saw firsthand what makes Exponent distinctive: an ecosystem of exceptional professionals that reaches across disciplines, industries, and geographies to solve our clients’ most complicated scientific and engineering challenges. Nearly six decades in the making, this ecosystem is extraordinarily difficult to replicate, and its value only grows as the problems our clients face become more complex and more consequential,” said Dr. Catherine Corrigan, Chief Executive Officer of Exponent.

“AI is accelerating that dynamic and creating entirely new classes of opportunities for Exponent. We have always operated at the edge, where new technologies encounter uncertainty, where innovation introduces new risks, and the hardest scientific and engineering questions have yet to be answered. Today, that edge is expanding, and so is the opportunity for Exponent,” Dr. Corrigan continued.

A video of the presentation portion of the day is available on the Investor Relations section of the Company’s website at www.exponent.com/investors.

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, and integrated technical platform work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward at speed.

Exponent may be reached at (888) 656­-EXPO, [email protected], or www.exponent.com.

Source: Exponent, Inc.
2026-09-28 11:54 1mo ago
2026-09-28 07:00 1mo ago
Aurora Mobile Showcases at Tourism EXPO Japan 2026: How AI is Solving the Travel Industry's Staffing Crisis
EXPO Exponent
FMP Stock News
Original source text
SINGAPORE, Sept. 28, 2026 (GLOBE NEWSWIRE) -- From September 24 to 25, the Tourism EXPO Japan 2026 took place at Tokyo Big Sight. Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services, was invited to co-exhibit as a sponsor of the Japan Web3 Tourism Association, demonstrating how AI technology is empowering the digital transformation of the tourism sector.

The Tourism Paradox: Booming Inbound Travel vs. Overstretched Staff
As inbound tourism to Japan reaches record highs, the industry is grappling with an unprecedented staffing crisis. Throughout the exhibition, frontline hospitality professionals voiced consistent operational frustrations: the inability to manage overnight inquiry backlogs, severe front-desk bottlenecks caused by language barriers with non-English-speaking groups, and a lack of manpower to produce dynamic video content for international marketing.

These challenges illustrate that the tourism sector's demand for AI has moved far beyond basic chatbots. What is urgently needed are "digital employees" capable of handling real workloads and executing complex operations.

Live on Site: AI Solutions Integrated into Real Workflows
At this exhibition, the Aurora Mobile Japan team presented EngageLab (customer engagement platform), GPTBots.ai (enterprise-grade AI agent platform), and Modellix.ai (unified AI media generation platform), conducting live demonstrations tailored to tourism scenarios:

Moving Beyond Translation Apps with 24/7 Multilingual AI Guides: By scanning QR codes at scenic spots or hotels, tourists can converse smoothly with AI in their native language (supporting 100+ languages). Whether searching for local cuisine or booking unique experiences, the AI provides precise recommendations based on real-time operational status and seamlessly guides the user to complete the booking process.Alleviating Customer Service Overload via EngageLab LiveDesk and GPTBots.ai: For high-frequency standard inquiries like "Are you open today?" or "Where is the parking lot?" as well as after-hours support gaps, AI Agents powered by GPTBots.ai provide 24/7 precise automated responses. When encountering highly complex or personalized needs, the system seamlessly routes the conversation to human agents via EngageLab LiveDesk. This efficient collaboration between AI agents and human staff within a single platform ensures an uninterrupted traveler experience while significantly reducing the strain on frontline employees.Eliminating Tedious Editing as Modellix.ai Brings Landscape Photos to Life: Addressing the promotional bottlenecks of local tourism boards and hotels, the site showcased Modellix.ai's video generation capabilities. By simply uploading a few static landscape or hotel room photos—and without needing a professional editing team—the AI automatically generates exquisite PR videos ready for social media distribution.
From Standalone Tools to End-to-End Workflows
As we have consistently emphasized at previous exhibitions, what enterprises truly need is not just another isolated AI tool, but a practical starting point that integrates smoothly into existing workflows. At this event, Aurora Mobile showcased not only cutting-edge technology but also deep synergy with current tourism service systems—allowing AI to handle standardized, high-frequency tasks, and freeing humans to provide deeper, more empathetic hospitality.

Moving forward, Aurora Mobile will continue to deepen its localized support, helping the global tourism industry accelerate its embrace of digital transformation.

About EngageLab
EngageLab is an AI-first customer engagement platform that helps you build stronger customer relationships with AI agents, unified customer data, and reliable delivery across channels.

EngageLab's global customers include Dhgate, HelloRide, The Consejo Nacional Electoral (CNE) of Ecuador, J&T Cargo, Blurams and many more.

For more information, please contact: [email protected]

About GPTBots.ai
GPTBots.ai is an enterprise-grade AI agent platform under Aurora Mobile (NASDAQ: JG), offering no-code/low-code AI agent development, deployment, and management for enterprise clients. Through multi-model LLM integration and intelligent workflow automation, GPTBots.ai empowers organizations to enhance customer service, optimize knowledge management, and automate business processes, driving digital innovation and transformation worldwide.

GPTBots.ai's global customers include Axios Management, GP Batteries, Echosens China, and many more.

For more information, please contact: [email protected]

About Modellix
Modellix is Aurora Mobile’s premier unified platform for AI media generation. It enables developers and enterprises to generate, track, and scale content using world-class models through a single, secure, and transparent API.

For more information, please contact: [email protected]

About Aurora Mobile
Founded in 2011, Aurora Mobile (NASDAQ: JG) is a leading provider of customer engagement and marketing technology services. The Company is dedicated to empowering global enterprises with stable, efficient, and intelligent customer interaction solutions. Leveraging its first-mover advantage in mobile messaging, Aurora Mobile has evolved into a comprehensive platform that integrates Omnichannel Engagement, AI-Driven Marketing, Advanced AI Customer Support, and Frictionless Identity Security. Through its flagship brand EngageLab and its robust AI infrastructure GPTBots.ai, the Company helps businesses achieve seamless customer reach, automate complex marketing journeys, and optimize service efficiency with AI agents, accelerating digital transformation for clients worldwide.

For more information, please visit: https://ir.aurora-mobile.com/

Media contact: [email protected]

Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Among other things, the Business Outlook and quotations from management in this announcement, as well as Aurora Mobile's strategic and operational plans, contain forward-looking statements. Aurora Mobile may also make written or oral forward-looking statements in its reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about Aurora Mobile's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Aurora Mobile's strategies; Aurora Mobile's future business development, financial condition and results of operations; Aurora Mobile's ability to attract and retain customers; its ability to develop and effectively market data solutions, and penetrate the existing market for developer services; its ability to transition to the new advertising-driven SAAS business model; its ability to maintain or enhance its brand; the competition with current or future competitors; its ability to continue to gain access to mobile data in the future; the laws and regulations relating to data privacy and protection; general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in the Company's filings with the Securities and Exchange Commission. All information provided in this press release and in the attachments is as of the date of the press release, and Aurora Mobile undertakes no duty to update such information, except as required under applicable law.

For more information, please contact:
Aurora Mobile Limited
E-mail: [email protected]

Christensen Advisory
Ms. Xiaoyan Su
E-mail: [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7ec171bc-8971-4167-8b83-6f8d0c56a7b5
2026-09-24 15:03 1mo ago
2026-09-24 05:22 1mo ago
Shukri Jeries Souri Acquires 184 Shares of Exponent (NASDAQ:EXPO) Stock
EXPO Exponent
FMP Stock News
Original source text
Exponent, Inc. (NASDAQ:EXPO – Get Free Report) VP Shukri Souri bought 184 shares of the firm’s stock in a transaction that occurred on Friday, September 18th. The stock was bought at an average cost of $68.45 per share, for a total transaction of $12,594.80. Following the completion of the transaction, the vice president directly owned 40,873 shares of the company’s stock, valued at approximately $2,797,756.85. The trade was a 0.45% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Exponent Stock Performance Exponent stock opened at $65.41 on Thursday. Exponent, Inc. has a 1 year low of $51.91 and a 1 year high of $81.95. The firm has a 50 day moving average price of $67.15 and a 200 day moving average price of $64.07. The company has a market cap of $3.11 billion, a price-to-earnings ratio of 29.33 and a beta of 0.68.

Exponent (NASDAQ:EXPO – Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The business services provider reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.55 by $0.05. Exponent had a net margin of 17.67% and a return on equity of 31.48%. The company had revenue of $171.61 million for the quarter, compared to the consensus estimate of $144.99 million. During the same quarter last year, the firm posted $0.52 earnings per share. Exponent’s revenue was up 12.0% on a year-over-year basis. Sell-side analysts predict that Exponent, Inc. will post 2.31 EPS for the current year.

Exponent Dividend Announcement The company also recently announced a quarterly dividend, which was paid on Friday, September 18th. Investors of record on Friday, September 4th were issued a $0.31 dividend. The ex-dividend date was Friday, September 4th. This represents a $1.24 dividend on an annualized basis and a yield of 1.9%. Exponent’s dividend payout ratio (DPR) is presently 55.61%. Wall Street Analyst Weigh In Several equities research analysts have commented on the company. JPMorgan Chase & Co. upped their price target on Exponent from $80.00 to $90.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Exponent in a research note on Friday, July 17th. Finally, UBS Group set a $72.00 target price on Exponent and gave the stock a “neutral” rating in a report on Friday, July 31st. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Exponent has an average rating of “Moderate Buy” and a consensus price target of $81.00.

Read Our Latest Stock Report on Exponent

Institutional Trading of Exponent Several large investors have recently added to or reduced their stakes in the stock. Quantinno Capital Management LP boosted its position in shares of Exponent by 114.3% in the first quarter. Quantinno Capital Management LP now owns 36,614 shares of the business services provider’s stock worth $2,389,000 after buying an additional 19,528 shares during the period. Royce & Associates LP grew its stake in shares of Exponent by 73.8% in the fourth quarter. Royce & Associates LP now owns 652,109 shares of the business services provider’s stock valued at $45,295,000 after buying an additional 276,889 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Exponent by 2.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 918,885 shares of the business services provider’s stock valued at $59,958,000 after buying an additional 20,270 shares during the period. New Age Alpha Advisors LLC raised its holdings in shares of Exponent by 785.8% during the 4th quarter. New Age Alpha Advisors LLC now owns 24,775 shares of the business services provider’s stock valued at $1,721,000 after buying an additional 21,978 shares during the period. Finally, Renaissance Technologies LLC acquired a new position in Exponent during the 1st quarter worth approximately $5,742,000. 92.37% of the stock is currently owned by institutional investors and hedge funds.

About Exponent (Get Free Report)

Exponent, Inc is a multidisciplinary engineering and scientific consulting company that helps clients investigate complex technical issues, manage risk and improve the safety, performance and reliability of products, systems and operations. Its work commonly involves failure analysis, accident reconstruction, product liability, materials and structures, biomechanics, environmental sciences and health, and human factors.

The company provides consulting, testing, research and expert-witness services to businesses, insurers, law firms and government agencies.

Featured Stories Five stocks we like better than Exponent Chips to Bots: Qualcomm’s Agentic AI Breakout Ciena Fell 40%—Now One Analyst Sees 50% Upside Energy Transfer Taps the AI Power Boom Viking’s Obesity Edge May Be Staying Power, Not Weight Loss

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.
2026-08-31 18:15 2mo ago
2026-08-31 04:29 2mo ago
Caisse de depot et placement du Quebec Takes Position in Exponent, Inc. $EXPO
EXPO Exponent
FMP Stock News
Original source text
Caisse de depot et placement du Quebec purchased a new stake in Exponent, Inc. (NASDAQ:EXPO – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 20,200 shares of the business services provider’s stock, valued at approximately $1,187,000.

Several other hedge funds have also made changes to their positions in the company. Bell Investment Advisors Inc grew its position in Exponent by 423.6% during the 1st quarter. Bell Investment Advisors Inc now owns 377 shares of the business services provider’s stock worth $25,000 after purchasing an additional 305 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Exponent in the second quarter valued at $26,000. Allworth Financial LP lifted its holdings in shares of Exponent by 86.1% in the fourth quarter. Allworth Financial LP now owns 469 shares of the business services provider’s stock valued at $33,000 after purchasing an additional 217 shares in the last quarter. Bessemer Group Inc. boosted its position in shares of Exponent by 37.1% in the first quarter. Bessemer Group Inc. now owns 717 shares of the business services provider’s stock worth $47,000 after buying an additional 194 shares during the period. Finally, Hantz Financial Services Inc. boosted its position in shares of Exponent by 129.0% in the fourth quarter. Hantz Financial Services Inc. now owns 907 shares of the business services provider’s stock worth $63,000 after buying an additional 511 shares during the period. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Wall Street Analyst Weigh In EXPO has been the topic of a number of research analyst reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Exponent in a report on Friday, July 17th. UBS Group set a $72.00 price objective on Exponent and gave the stock a “neutral” rating in a research note on Friday, July 31st. Finally, JPMorgan Chase & Co. raised their price objective on Exponent from $80.00 to $90.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, Exponent currently has an average rating of “Moderate Buy” and an average price target of $81.00.

Get Our Latest Analysis on Exponent Insider Transactions at Exponent In other Exponent news, CEO Catherine Corrigan sold 1,707 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $66.28, for a total value of $113,139.96. Following the transaction, the chief executive officer owned 129,108 shares in the company, valued at $8,557,278.24. The trade was a 1.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.70% of the company’s stock.

Exponent Stock Performance Exponent stock opened at $71.53 on Monday. Exponent, Inc. has a twelve month low of $51.91 and a twelve month high of $81.95. The firm has a market cap of $3.40 billion, a PE ratio of 32.08 and a beta of 0.68. The firm’s 50 day moving average price is $64.33 and its two-hundred day moving average price is $64.43.

Exponent (NASDAQ:EXPO – Get Free Report) last issued its earnings results on Thursday, July 30th. The business services provider reported $0.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.55 by $0.05. Exponent had a net margin of 17.67% and a return on equity of 31.48%. The company had revenue of $171.61 million during the quarter, compared to analyst estimates of $144.99 million. During the same quarter last year, the business posted $0.52 EPS. The company’s revenue for the quarter was up 12.0% on a year-over-year basis. Equities analysts anticipate that Exponent, Inc. will post 2.31 EPS for the current fiscal year.

Exponent Dividend Announcement The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 18th. Investors of record on Friday, September 4th will be given a dividend of $0.31 per share. The ex-dividend date of this dividend is Friday, September 4th. This represents a $1.24 dividend on an annualized basis and a yield of 1.7%. Exponent’s dividend payout ratio (DPR) is presently 55.61%.

About Exponent (Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

Featured Articles Five stocks we like better than Exponent Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally Rubrik’s AI Security Bet Could Power the Next Leg Higher Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.
2026-08-30 19:16 2mo ago
2026-08-29 04:00 2mo ago
Algert Global LLC Sells 104,110 Shares of Exponent, Inc. $EXPO
EXPO Exponent
FMP Stock News
Original source text
Algert Global LLC decreased its position in Exponent, Inc. (NASDAQ:EXPO – Free Report) by 69.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 45,120 shares of the business services provider’s stock after selling 104,110 shares during the period. Algert Global LLC owned approximately 0.09% of Exponent worth $2,651,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of EXPO. Northwestern Mutual Wealth Management Co. boosted its holdings in Exponent by 87,479.8% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 230,335 shares of the business services provider’s stock valued at $15,999,000 after acquiring an additional 230,072 shares during the last quarter. UBS Group AG lifted its position in shares of Exponent by 29.7% in the 4th quarter. UBS Group AG now owns 176,404 shares of the business services provider’s stock worth $12,253,000 after purchasing an additional 40,359 shares during the period. Conestoga Capital Advisors LLC lifted its position in shares of Exponent by 1.3% in the 4th quarter. Conestoga Capital Advisors LLC now owns 2,392,499 shares of the business services provider’s stock worth $166,183,000 after purchasing an additional 31,303 shares during the period. Quantinno Capital Management LP lifted its position in shares of Exponent by 114.3% in the 1st quarter. Quantinno Capital Management LP now owns 36,614 shares of the business services provider’s stock worth $2,389,000 after purchasing an additional 19,528 shares during the period. Finally, New Age Alpha Advisors LLC boosted its stake in shares of Exponent by 785.8% in the 4th quarter. New Age Alpha Advisors LLC now owns 24,775 shares of the business services provider’s stock valued at $1,721,000 after purchasing an additional 21,978 shares during the last quarter. Institutional investors own 92.37% of the company’s stock.

Insider Buying and Selling at Exponent In other Exponent news, CEO Catherine Corrigan sold 1,707 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $66.28, for a total transaction of $113,139.96. Following the completion of the sale, the chief executive officer directly owned 129,108 shares of the company’s stock, valued at approximately $8,557,278.24. The trade was a 1.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes A number of analysts have commented on the stock. JPMorgan Chase & Co. upped their price target on shares of Exponent from $80.00 to $90.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. UBS Group set a $72.00 price objective on Exponent and gave the company a “neutral” rating in a research note on Friday, July 31st. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Exponent in a research report on Friday, July 17th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $81.00. Get Our Latest Stock Report on Exponent

Exponent Stock Performance EXPO stock opened at $71.53 on Friday. The stock’s 50 day simple moving average is $64.33 and its 200 day simple moving average is $64.53. Exponent, Inc. has a fifty-two week low of $51.91 and a fifty-two week high of $81.95. The company has a market cap of $3.40 billion, a P/E ratio of 32.08 and a beta of 0.68.

Exponent (NASDAQ:EXPO – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The business services provider reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.55 by $0.05. Exponent had a return on equity of 31.48% and a net margin of 17.67%.The firm had revenue of $171.61 million during the quarter, compared to analysts’ expectations of $144.99 million. During the same quarter last year, the firm posted $0.52 earnings per share. The company’s revenue for the quarter was up 12.0% compared to the same quarter last year. Equities analysts predict that Exponent, Inc. will post 2.31 earnings per share for the current year.

Exponent Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Friday, September 18th. Investors of record on Friday, September 4th will be issued a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Friday, September 4th. Exponent’s dividend payout ratio is currently 55.61%.

Exponent Profile (Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

Featured Stories Five stocks we like better than Exponent 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude? Okta Stock Surges 29%—Is $200 the Next Stop?

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.
2026-08-20 15:44 2mo ago
2026-08-20 10:41 2mo ago
Are Business Services Stocks Lagging Exponent (EXPO) This Year?
EXPO Exponent
FMP Stock News
Original source text
Investors interested in Business Services stocks should always be looking to find the best-performing companies in the group. Exponent (EXPO - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.

Exponent is a member of our Business Services group, which includes 246 different companies and currently sits at #8 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Exponent is currently sporting a Zacks Rank of #2 (Buy).

Within the past quarter, the Zacks Consensus Estimate for EXPO's full-year earnings has moved 1.1% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.

Based on the most recent data, EXPO has returned 0.7% so far this year. At the same time, Business Services stocks have lost an average of 8.5%. As we can see, Exponent is performing better than its sector in the calendar year.

One other Business Services stock that has outperformed the sector so far this year is Gen Digital (GEN - Free Report) . The stock is up 1.3% year-to-date.

In Gen Digital's case, the consensus EPS estimate for the current year increased 2.3% over the past three months. The stock currently has a Zacks Rank #2 (Buy).

To break things down more, Exponent belongs to the Consulting Services industry, a group that includes 13 individual companies and currently sits at #45 in the Zacks Industry Rank. Stocks in this group have lost about 14.4% so far this year, so EXPO is performing better this group in terms of year-to-date returns.

On the other hand, Gen Digital belongs to the Technology Services industry. This 121-stock industry is currently ranked #150. The industry has moved -11.2% year to date.

Investors with an interest in Business Services stocks should continue to track Exponent and Gen Digital. These stocks will be looking to continue their solid performance.
2026-08-03 16:30 2mo ago
2026-08-03 10:56 2mo ago
Wall Street Analysts Predict a 25.65% Upside in Exponent (EXPO): Here's What You Should Know
EXPO Exponent
FMP Stock News
Original source text
Exponent (EXPO - Free Report) closed the last trading session at $66.85, gaining 9.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $84 indicates a 25.7% upside potential.

The mean estimate comprises three short-term price targets with a standard deviation of $10.39. While the lowest estimate of $72.00 indicates a 7.7% increase from the current price level, the most optimistic analyst expects the stock to surge 34.6% to reach $90.00. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable.

However, an impressive consensus price target is not the only factor that indicates a potential upside in EXPO. This view is strengthened by the agreement among analysts that the company will report better earnings than what they estimated earlier. Though a positive trend in earnings estimate revisions doesn't give any idea as to how much the stock could surge, it has proven effective in predicting an upside.

Price, Consensus and EPS Surprise

Here's What You May Not Know About Analysts' Price TargetsAccording to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.

While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?

They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.

However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.

That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with a high degree of skepticism.

Why EXPO Could Witness a Solid UpsideThere has been increasing optimism among analysts lately about the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher. And that could be a legitimate reason to expect an upside in the stock. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

The Zacks Consensus Estimate for the current year has increased 0.7% over the past month, as one estimate has gone higher compared to no negative revision.

Moreover, EXPO currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on four factors related to earnings estimates. Given an impressive externally-audited track record, this is a more conclusive indication of the stock's potential upside in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Therefore, while the consensus price target may not be a reliable indicator of how much EXPO could gain, the direction of price movement it implies does appear to be a good guide.
2026-07-31 05:43 3mo ago
2026-07-30 23:43 3mo ago
Exponent, Inc. (EXPO) Q2 2026 Earnings Call Transcript
EXPO Exponent
FMP Stock News
Original source text
Exponent, Inc. (EXPO) Q2 2026 Earnings Call Transcript
2026-07-31 00:55 3mo ago
2026-07-30 19:00 3mo ago
Exponent (EXPO) Surpasses Q2 Earnings and Revenue Estimates
EXPO Exponent
FMP Stock News
Original source text
Exponent (EXPO - Free Report) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.52 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +9.09%. A quarter ago, it was expected that this engineering and scientific consulting company would post earnings of $0.56 per share when it actually produced earnings of $0.59, delivering a surprise of +5.36%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Exponent, which belongs to the Zacks Consulting Services industry, posted revenues of $148.86 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 3.34%. This compares to year-ago revenues of $132.87 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Exponent shares have lost about 5.2% since the beginning of the year versus the S&P 500's gain of 6.9%.

What's Next for Exponent?While Exponent has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Exponent was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.60 on $146.92 million in revenues for the coming quarter and $2.28 on $586.57 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Consulting Services is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Information Services Group (III - Free Report) , has yet to report results for the quarter ended June 2026. The results are expected to be released on August 5.

This market advisory service company is expected to post quarterly earnings of $0.09 per share in its upcoming report, which represents a year-over-year change of +12.5%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Information Services Group's revenues are expected to be $62.75 million, up 1.9% from the year-ago quarter.
2026-07-31 00:55 3mo ago
2026-07-30 19:04 3mo ago
Exponent Q2 Earnings Call Highlights
EXPO Exponent
FMP Stock News
Original source text
7 best fintech ETFs to buy nowExponent NASDAQ: EXPO reported double-digit revenue and earnings growth for the second quarter of 2026, supported by demand for user research involving artificial intelligence-enabled products, utility-sector risk management work, and dispute-related consulting across consumer products, chemicals and transportation.

Total revenue increased 21% year over year to $171.6 million, while revenue before reimbursements, which the company calls net revenue, rose 12% to $148.9 million. Net income increased 11% to $29.4 million, and diluted earnings per share rose 15% to $0.60 from $0.52 a year earlier.

Get Exponent alerts:

How to Buy OpenAI Stock: A GuideChief Executive Officer Catherine Ford Corrigan said the company’s proactive work was led by demand for user research as clients accelerated development of AI-enabled products across a wider range of hardware formats and applications. Reactive work also grew, with clients seeking dispute-related expertise in consumer products, chemicals and transportation.

AI-Enabled Product Research Drives Growth Corrigan said Exponent’s user research engagements are becoming broader and more complex, often requiring a combination of human factors, biomechanics, engineering and data-science expertise. The company conducts studies designed to assess how people interact with products and technologies, including smart glasses, immersive technologies and health and wellness wearables.

How to Calculate Moving Average; How it Helps in Stock SelectionThe second quarter also benefited from one large user research study that represented about 4% of net revenue, above Exponent’s prior expectation that the project would account for roughly 2% of net revenue. Chief Financial Officer Eric Anderson said the project expanded in scope during the quarter, moderated toward the end of the period, and is expected to continue at a level of approximately 2% of net revenue through the rest of the year.

Anderson said the broader user-research business has expanded in the number of clients, projects and types of devices being evaluated. Corrigan said the company is seeing the work diversify beyond consumer electronics and into life sciences, including health-related wearables and more sophisticated medical-device applications.

During the question-and-answer session, Corrigan said AI is contributing to both proactive and reactive demand. In reactive work, she cited advanced driver-assistance technologies, where automotive product-liability matters increasingly involve questions around system performance, automated braking, driver distraction and driver monitoring. She also identified data-center infrastructure as a potential source of failure-analysis work involving cooling systems, power inverters and battery energy-storage systems.

Utility, Chemical and Transportation Demand Exponent said proactive activity was also supported by risk-management and infrastructure engagements in the utility sector. The company said clients are assessing the resilience and reliability of critical systems amid higher power demand, extreme weather and increasing electric-grid complexity.

In its reactive business, the company cited demand for product-safety, recall, incident-investigation and dispute work in consumer products. Chemical-sector activity included evaluating legacy substances and emerging chemicals of concern, while transportation work included failure analysis related to advanced driver-assistance systems.

President John Pye said AI is moving beyond purely digital applications and into physical products and systems such as vehicles, wearables, infrastructure and robotic systems. He said these technologies must operate reliably in unpredictable real-world conditions, creating a need for expertise across engineering, physical sciences, data science and human factors.

Corrigan identified consumer electronics, chemicals and utilities as key current verticals for proactive work. She said Exponent also sees opportunities in transportation and medical devices as regulation, product complexity and AI integration increase.

Margins, Utilization and Capital Returns Second-quarter EBITDA rose 16% to $42.7 million. EBITDA margin was 28.7% of net revenue, compared with 27.8% in the prior-year quarter.

Billable hours increased 8% to approximately 390,000. Average technical full-time employees increased 6% to 1,012, while utilization rose to 74% from 72% a year earlier. The company’s realized rate increase was about 4% during the quarter.

The engineering and other scientific segment, representing 85% of net revenue, recorded 13% net revenue growth. The environmental and health segment, representing 15% of net revenue, grew net revenue 9%, driven by work evaluating chemicals’ effects on human health and the environment.

Exponent repurchased $67.4 million of common stock during the quarter at an average price of $59.88 per share and paid $14.8 million in dividends. Over the past 12 months, the company returned $272 million to shareholders, including $211 million in share repurchases and $61 million in dividends. Its board approved a further $50 million increase to the stock-repurchase program.

Anderson said the company expects to remain active in repurchasing stock when shares pull back, though at a lower pace than in the first half of 2026 or the second half of 2025. He said Exponent expects to generate more than $100 million of free cash flow in the second half of 2026.

Full-Year Outlook Raised Exponent raised its 2026 outlook and now expects net revenue growth of 9% to 10%, with EBITDA representing 27.8% to 28.1% of net revenue. The company previously did not state its earlier full-year targets during the call.

For the third quarter, Exponent expects net revenue growth of 8% to 10% year over year and EBITDA margin of 28.0% to 28.5%. It expects average technical full-time-equivalent employees to rise 4% to 5% in the quarter and utilization of 74% to 75%.

For the full year, Exponent expects technical employee growth of 4.5% to 5%, utilization of 72.5% to 73%, and realized rate increases of 3.5% to 4%. Capital expenditures are projected at $12 million to $14 million.

About Exponent (NASDAQ:EXPO)Exponent, Inc NASDAQ: EXPO is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company's expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Exponent Right Now?Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
2026-07-30 22:31 3mo ago
2026-07-30 16:05 3mo ago
Exponent Reports Second Quarter 2026 Financial Results
EXPO Exponent
FMP Stock News
Original source text
MENLO PARK, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2026 ended July 3, 2026.

“Exponent delivered another strong quarter, with double-digit growth in revenues and earnings reflecting continued demand for our specialized expertise across industries,” stated Dr. Catherine Corrigan, Chief Executive Officer. “Our proactive work experienced strong growth in the quarter, led by demand for user research studies as clients accelerate the development of AI-enabled products across an increasingly diverse range of hardware form factors and applications, with engagements continuing to expand in scope, scale and complexity. Proactive activity was also supported by increased risk management and infrastructure-related engagements in the utility sector. Reactive work grew, with strong demand for our dispute-related expertise from the consumer products, chemicals, and transportation industries.

“These results reflect the powerful long-term trends driving our business, including rapid technological innovation, increasing complexity, growing energy demand, investment in resilient power and digital infrastructure, and rising expectations for safety, reliability, and performance. As artificial intelligence becomes embedded in an expanding array of physical products and systems, organizations face increasingly daunting human factors, operational, and risk management challenges that extend well beyond software. Clients turn to Exponent when they encounter critical questions involving the interaction of technology, people, and complex real-world environments, particularly when the consequences of failure are exceptionally high. Our multidisciplinary teams provide the independent, science-based insights needed to accelerate innovation, improve decision-making, and reduce high-consequence risk in areas where few organizations possess comparable expertise,” Dr. Corrigan continued.

Second Quarter Financial Results

Total revenues and revenues before reimbursements for the second quarter of 2026 increased 21% to $171.6 million and 12% to $148.9 million, respectively, as compared to $142.0 million and $132.9 million in the second quarter of 2025.

Net income increased to $29.4 million, or $0.60 per diluted share, in the second quarter of 2026, as compared to $26.6 million, or $0.52 per diluted share, in the same period of 2025. The tax impact associated with share-based awards was immaterial in both the second quarter of 2026 and 2025. Exponent’s consolidated tax rate was 27.9% in the second quarter of 2026, unchanged from the same period in 2025.

EBITDA1 increased to $42.7 million, or 28.7% of revenues before reimbursements, in the second quarter of 2026, as compared to $37.0 million, or 27.8% of revenues before reimbursements in the second quarter of 2025.

Year-to-Date Financial Results

Total revenues and revenues before reimbursements for the first half of 2026 increased 18% to $337.9 million and 11% to $300.7 million, respectively, as compared to $287.5 million and $270.3 million in the same period of 2025.

Net income increased to $59.0 million, or $1.19 per diluted share, in the first half of 2026, as compared to $53.2 million, or $1.03 per diluted share, in the same period of 2025. During the first half of 2026, we realized a negative tax impact associated with share-based awards of $0.8 million as compared to $0.5 million in the first half of 2025. Inclusive of the tax impact associated with share-based awards, Exponent’s consolidated tax rate was 29.0% in the first half of 2026, as compared to 28.7% for the same period last year.

EBITDA1 increased to $85.9 million, or 28.6% of revenues before reimbursements, in the first half of 2026, as compared to $74.5 million, or 27.6% of revenues before reimbursements, in the first half of 2025.

For the first half of 2026, Exponent paid $31.3 million in dividends, repurchased $146.1 million of common stock, and closed the period with $66.6 million in cash and cash equivalents.

In a separate press release today, Exponent announced its quarterly cash dividend of $0.31 to be paid on September 18, 2026, and reiterated its intent to continue to pay quarterly dividends. Additionally, Exponent’s Board of Directors approved an increase in the current stock repurchase program of $50 million.

Business Overview

Exponent’s engineering and other scientific segment represented 85% of the Company’s revenues before reimbursements in the second quarter and through the first two quarters of 2026. Revenues before reimbursements in this segment increased 13% during the second quarter and 12% during the first half of 2026, as compared to the prior year period. Growth during the quarter was driven by strong user research activity in consumer electronics, risk management and infrastructure-related work in the utilities sector, and reactive engagements across the consumer products, chemicals, and transportation industries.

Exponent’s environmental and health segment represented 15% of the Company’s revenues before reimbursements in the second quarter and through the first two quarters of 2026. Revenues before reimbursements in this segment increased 9% during the second quarter and 5% during the first half of 2026, as compared to the same period in the prior year. Growth during the quarter was driven by engagements evaluating the impacts of chemicals on human health and the environment.

Business Outlook

“Our second quarter results demonstrate continued disciplined execution across the business, with strong utilization of 74% contributing to performance that exceeded our expectations,” commented Eric Anderson, Chief Financial Officer. “We continued to invest in our talent and capabilities while maintaining a disciplined capital allocation strategy, returning a combined $272 million to shareholders over the last twelve months through share repurchases and our ongoing dividend program.”

For the third quarter of fiscal 2026 as compared to the same period one year prior, Exponent anticipates:

Revenues before reimbursements to grow 8% to 10%; and,EBITDA1 to be 28.0% to 28.5% of revenues before reimbursements. For the full fiscal year 2026 as compared to fiscal year 2025, Exponent is raising its revenue and margin guidance, anticipating:

Revenues before reimbursements to grow 9% to 10%; and,EBITDA1 to be 27.8% to 28.1% of revenues before reimbursements. “Exponent remains well positioned to support clients as emerging technologies, critical infrastructure, and increasingly complex and interconnected systems reshape industries around the world,” Dr. Corrigan said. “Whether helping clients evaluate AI-enabled products, enhancing the resilience and performance of infrastructure, or navigating complex technical and regulatory challenges, our expert ecosystem provides the rigorous, independent insights needed when the stakes are high. We remain confident in our ability to expand our impact across industries and deliver long-term value for our shareholders.”

Today’s Conference Call Information

Exponent will discuss its financial results in more detail on a conference call today, Thursday, July 30, 2026, starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. The audio of the conference call is available by dialing (844) 481-2781 or (412) 317-0672. A live webcast of the call will be available on the Investor Relations section of the Company’s website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent website, or by dialing (855) 669-9658 or (412) 317-0088 and entering passcode 7563057#.

Use of non-GAAP Financial Measures 1

EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation, and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income, and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present, and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position, or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.

Exponent has provided its outlook regarding EBITDA as a percentage of revenues before reimbursements. The Company has not reconciled this non-GAAP financial measure to the corresponding GAAP financial measure because guidance for the various reconciling items is not provided and the Company is unable to estimate with reasonable certainty the effect of these items without unreasonable effort. For example, the Company is unable to estimate with reasonable certainty the impact of equity awards on Exponent’s taxes without unreasonable effort. These items are uncertain, depend on various factors, and may have a material effect on Exponent’s results computed in accordance with GAAP. A reconciliation between the historical GAAP and non-GAAP financial measures presented in this release is provided in the financial tables at the end of this release.

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, and integrated technical platform work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward at speed.

Exponent may be reached at (888) 656­-EXPO, [email protected], or www.exponent.com.

Forward Looking Statements

This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

Source: Exponent, Inc.

 EXPONENT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
For the Three and Six Months Ended July 3, 2026 and July 4, 2025
(unaudited)
(in thousands, except per share data)
                         Quarter Ended
 Six Months Ended
   July 3,
 July 4,
 July 3,
 July 4,
   2026
 2025
 2026
 2025
              Revenues            Revenues before reimbursements$148,860  $132,868  $300,677  $270,305  Reimbursements 22,752   9,094   37,238   17,164                 Revenues 171,612   141,962   337,915   287,469               Operating expenses            Compensation and related expenses 100,571   97,474   191,980   173,377  Other operating expenses 12,865   12,072   25,690   24,167  Reimbursable expenses 22,752   9,094   37,238   17,164  General and administrative expenses 7,402   6,145   13,606   11,152                   143,590   124,785   268,514   225,860                 Operating income 28,022   17,177   69,401   61,609               Other income            Interest income, net 716   2,344   2,434   5,058  Miscellaneous income (expense), net 12,028   17,294   11,270   7,908     12,744   19,638   13,704   12,966                 Income before income taxes 40,766   36,815   83,105   74,575               Income taxes 11,371   10,262   24,141   21,372                               Net income$29,395  $26,553  $58,964  $53,203                             Net income per share:            Basic$0.60  $0.52  $1.20  $1.04  Diluted$0.60  $0.52  $1.19  $1.03               Shares used in per share computations:            Basic 48,753   51,185   49,271   51,234  Diluted 48,987   51,502   49,571   51,587                 EXPONENT, INC.CONDENSED CONSOLIDATED BALANCE SHEETSJuly 3, 2026 and January 2, 2026(unaudited)(in thousands)                  July 3, January 2,    2026
 2026
   Assets   Current assets:
    Cash and cash equivalents$66,629  $221,930  Accounts receivable, net 218,504   181,507  Prepaid expenses and other assets 26,881   24,143   Total current assets 312,014   427,580 Property, equipment and leasehold improvements, net 70,854   71,981 Operating lease right-of-use asset 68,954   73,376 Goodwill
 8,607   8,607 Other assets
 192,294   195,975     $652,723  $777,519           Liabilities and Stockholders' Equity   Current liabilities:    Accounts payable and accrued liabilities$26,942  $30,942  Accrued payroll and employee benefits 102,186   121,302  Deferred revenues 21,953   18,868  Operating lease liability 6,757   6,890   Total current liabilities 157,838   178,002 Other liabilities
 132,305   133,232 Operating lease liability 73,964   75,944   Total liabilities 364,107   387,178        Stockholders' equity:    Common stock 66   66  Additional paid-in capital 389,568   369,747  Accumulated other comprehensive loss (2,378)  (2,290) Retained earnings 696,405   668,423  Treasury stock, at cost (795,045)  (645,605)   Total stockholders' equity 288,616   390,341     $652,723  $777,519          EXPONENT, INC.EBITDA and EBITDAS (1)For the Three and Six Months Ended July 3, 2026 and July 4, 2025(unaudited)(in thousands)                   Quarter Ended Six Months Ended   July 3, July 4, July 3, July 4,   2026
 2025
 2026
 2025
          Net Income$29,395  $26,553  $58,964  $53,203           Add back (subtract):                  Income taxes 11,371   10,262   24,141   21,372  Interest income, net (716)  (2,344)  (2,434)  (5,058) Depreciation and amortization 2,678   2,520   5,193   5,012             EBITDA (1) 42,728   36,991   85,864   74,529            Stock-based compensation 6,680   5,246   15,738   13,426             EBITDAS (1)$49,408  $42,237  $101,602  $87,955                               (1) EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.          
2026-07-30 22:31 3mo ago
2026-07-30 16:05 3mo ago
Exponent Declares Regular Quarterly Dividend for Q3 2026 and Increases Stock Repurchase Authorization by $50 Million
EXPO Exponent
FMP Stock News
Original source text
July 30, 2026 16:05 ET  | Source: Exponent, Inc.

MENLO PARK, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.31 per share of common stock to be paid on September 18, 2026, to all common stockholders of record as of September 4, 2026.

Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent’s Board of Directors.

In addition, Exponent’s Board of Directors increased the Company’s authority to repurchase shares of its common stock by $50 million.

“Our quarterly dividend and increased share repurchase authorization reflects the strength and durability of Exponent’s business model and our disciplined approach to capital allocation,” commented Dr. Catherine Corrigan, Chief Executive Officer. “Supported by our strong financial foundation and differentiated market position, we remain committed to returning capital to shareholders while investing in long-term growth opportunities.”

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, and integrated technical platform work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward at speed.

Exponent may be reached at (888) 656­-EXPO, [email protected], or www.exponent.com.

Forward Looking Statements

This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.
2026-07-09 22:14 3mo ago
2026-07-09 17:30 3mo ago
Exponent to Announce Second Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on July 30, 2026
EXPO Exponent
FMP Stock News
Original source text
July 09, 2026 17:30 ET  | Source: Exponent, Inc.

MENLO PARK, Calif., July 09, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Second Quarter of fiscal year 2026 financial results for the period ended July 3, 2026 following the close of the market on Thursday, July 30, 2026. On that day, Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company’s business and financial results.

Event:Exponent, Inc. Second Quarter of Fiscal Year 2026 Financial Results Conference CallDate:Thursday, July 30, 2026Time:4:30 p.m. Eastern Time / 1:30 p.m. Pacific TimeLive Call:(844) 481-2781 or (412) 317-0672   Exponent will also offer a live and archived webcast of the conference call, accessible from the Investor Relations section of the company's website, http://www.exponent.com/investors. A telephonic replay of the conference call will be available until Thursday, August 6, 2026 by dialing (855) 669-9658 or (412) 317-0088 and entering passcode 7563057#.

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent's consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent's offices in North America, Asia, and Europe. Exponent's consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward. 

Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.
2026-07-07 19:55 3mo ago
2026-07-07 13:58 3mo ago
Exponent: AI Makes The Work More Complex, Not Less Valuable
EXPO Exponent
FMP Stock News
Original source text
Exponent Inc. receives a buy rating, driven by its expert consulting model in high-stakes, complex technical domains. EXPO's value proposition lies in its deep technical talent, critical for problems where failure is costly and regulatory scrutiny is high. The AI debate is a catalyst: rising complexity in physical systems should increase demand for EXPO's services, not diminish it.
2026-06-20 08:52 4mo ago
2026-06-17 16:05 4mo ago
Exponent to Host Investor Day at Phoenix Test & Engineering Center
EXPO Exponent
FMP Stock News
Original source text
Company to showcase differentiated scientific and engineering capabilities, multidisciplinary expertise, and innovation-driven growth strategy June 17, 2026 16:05 ET  | Source: Exponent, Inc.

MENLO PARK, Calif., June 17, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), a leading engineering and scientific consulting firm, today announced that it will host an Investor Day at the Company’s Phoenix Test & Engineering Center on September 29, 2026, beginning at 8:30 a.m. Pacific Time.

The half-day event will feature presentations from Exponent’s executive leadership team and key market leaders, highlighting the Company’s premium service offerings, bespoke multidisciplinary solutions, and growth opportunities driven by rapid innovation, rising expectations for safety and performance, and unprecedented capital deployment into AI infrastructure.

Attendees will also tour Exponent’s Phoenix Test & Engineering Center and experience firsthand the Company’s advanced testing, failure analysis, and engineering capabilities through live demonstrations. The tour will showcase how Exponent helps clients address complex challenges at the intersection of hardware, software, AI-enabled systems, and human behavior – particularly where safety, reliability, and performance are critical.

“Our Investor Day will provide an opportunity to showcase the expertise, technical rigor, and collaborative culture that have made Exponent a trusted advisor to many of the world’s leading companies,” said Dr. Catherine Corrigan, Chief Executive Officer of Exponent. “As artificial intelligence and other emerging technologies become increasingly embedded within physical products, infrastructure, and critical systems, we see expanding opportunities for Exponent’s multidisciplinary expertise to support safety, reliability, performance, and risk mitigation. We look forward to highlighting how Exponent is uniquely positioned to support clients as innovation accelerates and system complexity grows.”

The program will highlight several key elements of Exponent’s differentiated model, including:

A uniquely multidisciplinary platform spanning more than 90 technical disciplines, enabling the firm to address highly complex, high-stakes engineering and scientific challengesDeep technical expertise and independent scientific analysis supporting mission critical decision-makingIndustry-leading capabilities in failure analysis, testing, reliability, and risk assessment for complex products and systemsExposure to long-term secular growth trends including AI and machine learning, autonomous systems, robotics, advanced consumer electronics, medical devices, energy, and data centers “Exponent’s value proposition is grounded in scientific excellence, independence, and the ability to solve problems that few organizations are equipped to address,” said Dr. John Pye, President of Exponent. “We look forward to giving investors an inside view into the expertise, infrastructure, and innovation that will continue to drive our long-term growth.”

Additional details, including registration information, will be provided closer to the event date.

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, and integrated technical platform work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward at speed.

Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.
2026-06-12 13:48 4mo ago
2026-03-13 03:56 7mo ago
First Trust Advisors LP Grows Stake in Exponent, Inc. $EXPO
EXPO Exponent
FMP Stock News
Original source text
First Trust Advisors LP lifted its stake in shares of Exponent, Inc. (NASDAQ: EXPO) by 135.8% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 580,134 shares of the business services provider's stock after purchasing an additional 334,154 shares
2026-06-12 13:48 4mo ago
2026-03-16 12:08 7mo ago
EXPO® Brings Back Iconic Yellow Dry Erase Marker
EXPO Exponent
FMP Stock News
Original source text
After years of demand, the beloved color returns, powered by EXPO's new vibrant ink technology in time for the brand's 50th anniversary.

, /PRNewswire/ -- The EXPO® Yellow Dry Erase Marker, part of the Newell Brands portfolio, is back and brighter than ever. After years of requests from educators, organizers and longtime fans, the iconic shade is officially returning to the lineup following the introduction of EXPO's vibrant ink technology in 2025.

Back by Popular Demand: EXPO Reintroduces Its Iconic Yellow Dry Erase Marker

Designed for bold visibility and smooth, consistent performance, EXPO Yellow features the brand’s most vibrant ink yet. Yellow has historically been one of the most challenging colors for dry erase markers because it must be bright enough to stand out clearly on writing surfaces. With advances in EXPO's ink technology, Newell's Research and Development team enhanced the formula, so Yellow now pops on whiteboards and clear surfaces like windows.

"Yellow is a color consumers have asked us to bring back again and again," said Kris Malkoski, President, Learning & Development, Newell. "Teachers often use yellow to draw the sun and office workers gravitate to it to highlight key ideas on the board. With EXPO's vibrant ink innovation, we're excited to bring Yellow back with a bold, highly visible ink designed to stand out."

Since its discontinuation nearly two decades ago, EXPO Yellow has remained a nostalgic favorite among teachers and students who remember it as a staple of classroom color-coding systems and as a cheerful pop of color during lessons. Over the years, hundreds of consumers have asked for its return and kept the conversation alive on social media. Creators like TikToker @teachwithmx.ram, whose videos celebrate classic classroom tools, helped reignite conversation around the return of EXPO Yellow.

The return of the coveted yellow hue is powered by EXPO's new vibrant ink, introduced in 2025 across the full dry erase marker line. The improved ink delivers brighter, more saturated color designed to increase visibility on whiteboards, clear surfaces like glass, and other non-porous surfaces, making writing easier to read from a distance.

EXPO has been a partner in organizing ideas, teaching lessons, and planning everyday life for 50 years and continues to do that by listening to the people who use it most and introducing solutions to make the complicated, simple – and the simple, inspiring.

Availability
EXPO Yellow Dry Erase Markers are available now at Target and will be available at major retailers including Amazon, Walmart, Office Depot and Staples in the coming weeks. Yellow is available in both Fine Tip and Chisel Tip across various color assortments and pack sizes, including:

EXPO Dry Erase Fine Tip 12ct Assorted – Starting at $13.49 EDLP EXPO Dry Erase Chisel Tip 21ct Assorted – Starting at $21.99 EDLP EXPO Dry Erase Fine Tip 21ct Assorted – Starting at $21.99 EDLP About EXPO®
EXPO® is America's leading brand of dry and wet erase markers, trusted by teachers, professionals, parents, and creatives for bold color, clean erasing, and reliable performance. Designed to help people stay in control, EXPO products are Made for Change™ to keep ideas and plans flexible. EXPO is part of the Newell Brands global portfolio of leading brands.

About Newell Brands
Newell Brands (NASDAQ: NWL) is a leading global consumer goods company with a strong portfolio of well-known brands, including Rubbermaid, Sharpie®, Graco®, Coleman®, Rubbermaid Commercial Products®, Yankee Candle®, Paper Mate®, FoodSaver®, Dymo®, EXPO®, Elmer's®, Oster®, NUK®, Spontex® and Campingaz®. Newell Brands is focused on delighting consumers by lighting up everyday moments.

SOURCE Newell Brands
2026-06-12 13:48 4mo ago
2026-03-16 14:51 7mo ago
3 Stocks to Consider From the Prospering Consulting Services Industry
EXPO Exponent
FMP Stock News
Original source text
Economic strength, encouraging service activities, and the success of the work-from-home trend enable Zacks Consulting Services industry players to meet demand.
Driven by these positives, investors interested in the industry would do well to consider including stocks like Stantec Inc. (STN - Free Report) , FTI Consulting, Inc. (FCN - Free Report) and Exponent, Inc. (EXPO - Free Report) in their portfolios.

About the Industry Companies grouped under the Consulting Services category offer professional advice in management, IT, human resources, environmental regulations, logistics, marketing and real estate, serving multiple end markets. The space includes prominent names such as Accenture and Gartner. The industry focuses on channeling money and efforts toward more effective operational components, such as technology, digital transformation and data-driven decision-making. To position themselves suitably in the post-pandemic era and better utilize the opportunities that an economic recovery will bring, service providers are increasing their efforts to formulate and reassess strategic initiatives, identify sources of demand and target end markets.

What's shaping the Future of the Consulting Services Industry? Exponential Growth: This multi-billion-dollar industry has entered a trajectory of exponential expansion since the 2008 financial crisis, fueled by digital transformation and innovation-driven efficiencies. The trend has sustained steady revenues, profits and cash-flow growth, enabling most industry players to distribute stable dividends.

Economic Recovery: The sector is a major beneficiary of the broader economy and increasingly digital-driven service activities. According to the second estimate released by the Bureau of Economic Analysis, the economy remained resilient, with GDP growing 0.7% in the fourth quarter of 2025 against a 4.4% increase in the third quarter. Non-manufacturing activities remained strong, as reflected in the February Services PMI, which stayed above the 50% threshold for the 20th consecutive month.

Strong Demand Environment: The consulting services industry remains among the least disrupted by recent global uncertainties. Even in volatile conditions, organizations seek extensive guidance on safeguarding their workforce while strengthening ties with consumers and shareholders. The industry was an early pioneer of remote collaboration, now embedded in the new normal. Its work model allows players to operate efficiently, increasingly powered by AI-driven insights, digital platforms, and agile delivery frameworks.

Zacks Industry Rank Indicates Bright Prospects The Consulting Services industry, which is housed within the broader Business Services sector, currently carries a Zacks Industry Rank of #70. This rank places it in the top 29% of 243 Zacks industries.

The group’s Zacks Industry Rank, which is the average of the Zacks Rank of all the member stocks, indicates solid near-term growth prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than two to one.

Before we present a few stocks that you may want to consider for your portfolio, let’s take a look at the industry’s recent stock market performance and current valuation.

Industry's Price Performance The Consulting Services industry has underperformed the S&P 500 composite and the broader sector in the past year. The industry has declined 37.4% against the S&P 500 composite’s growth of 20% and the broader sector’s 19.3% decline.

One-Year Price Performance

Industry's Current Valuation On the basis of the forward 12-month price-to-earnings (P/E), which is a commonly used multiple for valuing consulting services companies, we see that the industry is currently trading at 15.55X, above the S&P 500’s 21.39X and the sector’s 17.53X.

Over the past five years, the industry has traded as high as 31.53X and as low as 15.55X, with a median of 26.58X, as the charts below show.

Price to Forward 12 Months P/E Ratio

3 Consulting Services Stocks to Consider FTI Consulting: The company’s diversified offerings and international operations strengthen top-line growth prospects. In 2025, the company generated nearly 34% of its revenues from its international operations. The broad range of practices and services, diversified revenue streams, specialized industry expertise and global reach differentiate FTI Consulting from its competitors. This diversification enables the company to mitigate the impacts of economic cycles, crises, events, and changes in a particular practice, industry, or country.

The Zacks Consensus Estimate for the company’s 2026 EPS has increased 2.2% in the past 60 days to $9.33. FCN currently carries a Zacks Rank #2 (Buy). The stock gained 6% in the past month. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. 

Price and Consensus: FCN

Exponent: Technological innovation continues to raise both complexity and safety expectations, and Exponent is well-positioned to capitalize on these shifts. With a strong foundation of talent and deep multidisciplinary expertise, the company delivered growth in dispute-related activities across construction, automotive and medical devices.

Proactive risk management work in the utilities sector further supported performance, offsetting softer demand in chemical regulatory engagements. Encouragingly, momentum is building in early-stage work tied to digital health, AI usability and distributed energy systems, areas with substantial growth potential. These drivers underscore Exponent’s ability to achieve sustainable growth and create long-term shareholder value.

The Zacks Consensus Estimate for the company’s 2026 EPS has increased by nearly 1% in the past 60 days to $2.27. The stock has surged 8% in the past month. EXPO currently carries a Zacks Rank #2.

Price and Consensus: EXPO

Stantec: The company provides professional services in the areas of infrastructure and facilities. It remains well-positioned for continued success, supported by industry resilience and effective internal strategies. The company benefits from strong macroeconomic and structural drivers while maintaining sharp execution on its projects, enabling margin expansion and earnings growth.

Stantec operates in a resilient sector shaped by long-term global needs, including water security, aging infrastructure, climate change response, advanced manufacturing and emerging technologies. These trends are expected to sustain strong project demand across regions.

Stantec’s consistent focus on high-quality project execution and addressing clients’ most urgent infrastructure and sustainability challenges supports steady growth. This disciplined approach continues to drive margin improvement and robust earnings performance.

The Zacks Consensus Estimate for the company’s 2025 EPS increased 6.4% in the past 60 days to $4.48. STN currently carries a Zacks Rank #2.

Price and Consensus: STN
2026-06-12 13:48 4mo ago
2026-04-04 05:01 6mo ago
SG Americas Securities LLC Increases Stock Holdings in Exponent, Inc. $EXPO
EXPO Exponent
FMP Stock News
Original source text
Posted by Defense World Staff on Apr 4th, 2026

SG Americas Securities LLC raised its position in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) by 422.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 36,610 shares of the business services provider’s stock after purchasing an additional 29,600 shares during the quarter. SG Americas Securities LLC owned 0.07% of Exponent worth $2,543,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in EXPO. Hantz Financial Services Inc. boosted its holdings in shares of Exponent by 97.0% in the third quarter. Hantz Financial Services Inc. now owns 396 shares of the business services provider’s stock worth $28,000 after buying an additional 195 shares during the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in Exponent during the third quarter valued at approximately $33,000. Winnow Wealth LLC purchased a new stake in Exponent during the third quarter valued at approximately $34,000. Pilgrim Partners Asia Pte Ltd bought a new position in Exponent in the third quarter worth approximately $38,000. Finally, GAMMA Investing LLC raised its position in Exponent by 50.4% in the fourth quarter. GAMMA Investing LLC now owns 576 shares of the business services provider’s stock worth $40,000 after acquiring an additional 193 shares during the period. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Exponent Price Performance Shares of NASDAQ:EXPO opened at $66.56 on Friday. The company has a market capitalization of $3.28 billion, a P/E ratio of 32.00 and a beta of 0.80. Exponent, Inc. has a 1-year low of $63.25 and a 1-year high of $83.92. The firm’s 50 day simple moving average is $69.86 and its two-hundred day simple moving average is $70.47.

Exponent (NASDAQ:EXPO – Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The business services provider reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.47 by $0.02. Exponent had a net margin of 18.21% and a return on equity of 25.51%. The firm had revenue of $147.43 million during the quarter, compared to analysts’ expectations of $128.48 million. During the same period in the prior year, the company posted $0.46 earnings per share. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, sell-side analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Exponent Increases Dividend The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Friday, March 6th were given a $0.31 dividend. The ex-dividend date was Friday, March 6th. This is a positive change from Exponent’s previous quarterly dividend of $0.30. This represents a $1.24 annualized dividend and a dividend yield of 1.9%. Exponent’s dividend payout ratio (DPR) is presently 59.62%.

Insider Transactions at Exponent In related news, CEO Catherine Corrigan sold 3,920 shares of the stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $67.15, for a total transaction of $263,228.00. Following the completion of the sale, the chief executive officer owned 93,731 shares in the company, valued at approximately $6,294,036.65. This trade represents a 4.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP John Pye sold 4,000 shares of Exponent stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $75.97, for a total value of $303,880.00. Following the sale, the vice president directly owned 25,204 shares in the company, valued at $1,914,747.88. This trade represents a 13.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 9,583 shares of company stock valued at $687,709. Corporate insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets A number of brokerages have recently issued reports on EXPO. JPMorgan Chase & Co. cut their price objective on shares of Exponent from $100.00 to $95.00 and set an “overweight” rating for the company in a research report on Thursday, March 26th. UBS Group reiterated a “neutral” rating and set a $85.00 target price on shares of Exponent in a research report on Monday, February 9th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Exponent in a report on Thursday, January 22nd. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Exponent currently has a consensus rating of “Moderate Buy” and an average price target of $90.00.

Check Out Our Latest Analysis on Exponent

Exponent Profile (Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

Read More Five stocks we like better than Exponent

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAmerican Financial Group, Inc. $AFG Shares Bought by SG Americas Securities LLC

NEXT HEADLINE »Global X Japan Co. Ltd. Has $90.55 Million Stock Holdings in NVIDIA Corporation $NVDA
2026-06-12 13:48 4mo ago
2026-04-06 16:35 6mo ago
Exponent Elevates John Pye to President and Eric Anderson to CFO Reporting to Catherine Corrigan, CEO; Rich Schlenker to Remain as Executive VP and to Stand for Election to Board of Directors
EXPO Exponent
FMP Stock News
Original source text
MENLO PARK, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), a leading engineering and scientific consulting firm, today announced its appointment of John Pye to President and Eric Anderson to Chief Financial Officer, both effective May 1, 2026 and reporting to Catherine Corrigan, Chief Executive Officer; nomination of Richard Schlenker, Executive Vice President and current Chief Financial Officer to stand for election to the Board of Directors; and the appointment of Karen Richardson as Chairman of the Board upon the retirement of Paul Johnston effective as of the Annual Meeting of Stockholders to be held on June 4, 2026.
2026-06-12 13:48 4mo ago
2026-04-09 16:05 6mo ago
Exponent to Announce First Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on April 30, 2026
EXPO Exponent
FMP Stock News
Original source text
April 09, 2026 16:05 ET  | Source: Exponent, Inc.

MENLO PARK, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report First Quarter of fiscal year 2026 financial results for the period ended April 3, 2026 following the close of the market on Thursday, April 30, 2026. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company’s business and financial results.

Event:Exponent, Inc. First Quarter of Fiscal Year 2026 Financial Results Conference CallDate:Thursday, April 30, 2026Time:4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time Live Call:(844) 481-2781 or (412) 317-0672   Exponent will also offer a live and archived webcast of the conference call, accessible from the Investor Relations section of the company's website, http://www.exponent.com/investors. A telephonic replay of the conference call will be available until Thursday, May 7, 2026 by dialing (855) 669-9658 or (412) 317-0088 and entering passcode 4146822#. 

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent's consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent's offices in North America, Asia, and Europe. Exponent's consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.

Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.
2026-06-12 13:47 4mo ago
2026-04-21 10:58 6mo ago
Exponent CEO Sells $529K in Stock as Company Eyes High Single-Digit Revenue Growth in 2026
EXPO Exponent
FMP Stock News
Original source text
Catherine Corrigan, the president and CEO of Exponent (EXPO +2.29%), reported the sale of 7,821 shares of common stock for approximately $529,000 via open-market transactions between March 16, 2026 and April 15, 2026, according to a SEC Form 4 filing.

Transaction summaryMetricValueShares sold (direct)7,821Transaction value~$529,000Post-transaction shares (direct)104,359Post-transaction value (direct ownership)~$7.13 millionTransaction value based on SEC Form 4 weighted average purchase price ($67.59); post-transaction value based on April 15, 2026 market close ($67.59).

Key questionsHow does the transaction affect Corrigan's ownership in Exponent?
The sale reduced Corrigan's direct common stock holdings by 6.97%, leaving her with 104,359 directly owned shares; she retains non-qualified stock options that may be exercised in the future.What was the nature of the transaction from a derivative perspective?
The shares sold were created through the exercise of options, with 7,821 shares immediately sold in the open market, indicating the transaction was primarily for liquidity following option vesting rather than a reduction in core investment.How does the transaction size compare to Corrigan's recent trading activity?
While Corrigan's prior trades were mostly administrative and smaller in size, this event is consistent with routine annual or periodic exercises and sales, and reflects the available share capacity after recent option-related activity.What is the context of Exponent's stock performance at the time of sale?
Exponent shares were priced at around $67.59 on the transaction dates and closed at $68.29 on April 15, 2026; the stock had declined 11.58% over the prior year, providing a neutral backdrop for option-driven insider sales.Company overviewMetricValueRevenue (TTM)$582.01 millionNet income (TTM)$106.01 millionDividend yield1.72%1-year price change-11.58%* 1-year price change calculated as of April 15, 2026.

Company snapshotExponent offers specialized consulting services across approximately 90 technical disciplines, including engineering, environmental sciences, and health sciences.The company generates revenue by providing scientific and engineering consulting services to address complex client challenges.It serves a diversified client base spanning chemical, construction, consumer products, energy, food and nutrition, government, life sciences, insurance, manufacturing, technology, transportation, and related sectors.Exponent operates as a global consulting firm with a focus on science and engineering solutions. The company’s strategy centers on delivering high-value, multidisciplinary expertise to address technically demanding problems for a broad range of industries. Exponent’s competitive edge lies in its ability to integrate advanced scientific knowledge with practical industry experience, supporting clients in risk management, regulatory compliance, and innovation.

What this transaction means for investorsCorrigan is navigating a meaningful leadership transition while still holding more than 104,000 common shares directly and retaining unexercised options, which keeps her skin in the game despite this sale. Effective May 1, John Pye steps into a newly created president role, and Eric Anderson takes over as CFO. The changes are interesting given that the stock has pulled back significantly from its 52-week high, trading around $67.85, or 15% below highs from this past year and highlighting the uncertainty around the latest executive changes and potentially even stock sales like this one.

Nevertheless, fundamentals have been holding up even if lackluster growth has disappointed investors. Fiscal year 2025 revenues before reimbursements came in at $536.8 million, up 3.5%, with net income up 5% to $106 million, or $2.07 per diluted share. Management guided for high single-digit net revenue growth in 2026, and the board raised the quarterly dividend to $0.31 per share. Ultimately, investors should watch whether management meets these goals.

Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
2026-06-12 13:47 4mo ago
2026-04-23 04:04 6mo ago
Exponent (EXPO) Expected to Announce Earnings on Thursday
EXPO Exponent
FMP Stock News
Original source text
Posted by Defense World Staff on Apr 23rd, 2026

Exponent (NASDAQ:EXPO – Get Free Report) is expected to be issuing its Q1 2026 results after the market closes on Thursday, April 30th. Analysts expect the company to announce earnings of $0.56 per share and revenue of $149.5290 million for the quarter. Interested persons can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Thursday, April 30, 2026 at 4:30 PM ET.

Exponent (NASDAQ:EXPO – Get Free Report) last released its quarterly earnings results on Thursday, February 5th. The business services provider reported $0.49 EPS for the quarter, beating the consensus estimate of $0.47 by $0.02. Exponent had a net margin of 18.21% and a return on equity of 25.51%. The business had revenue of $147.43 million during the quarter, compared to analyst estimates of $128.48 million. During the same period in the prior year, the firm posted $0.46 earnings per share. The company’s quarterly revenue was up 4.5% on a year-over-year basis. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Exponent Stock Performance NASDAQ:EXPO opened at $67.56 on Thursday. The company’s 50-day simple moving average is $68.19 and its 200-day simple moving average is $70.30. Exponent has a fifty-two week low of $63.25 and a fifty-two week high of $83.92. The stock has a market capitalization of $3.28 billion, a P/E ratio of 32.48 and a beta of 0.80.

Exponent Increases Dividend The company also recently announced a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Friday, March 6th were given a dividend of $0.31 per share. The ex-dividend date of this dividend was Friday, March 6th. This is a positive change from Exponent’s previous quarterly dividend of $0.30. This represents a $1.24 dividend on an annualized basis and a yield of 1.8%. Exponent’s dividend payout ratio is currently 59.62%.

Wall Street Analysts Forecast Growth Several equities analysts have issued reports on the stock. JPMorgan Chase & Co. cut their price target on shares of Exponent from $100.00 to $95.00 and set an “overweight” rating on the stock in a report on Thursday, March 26th. Weiss Ratings restated a “hold (c-)” rating on shares of Exponent in a research note on Thursday, January 22nd. Finally, UBS Group reiterated a “neutral” rating and issued a $85.00 price target on shares of Exponent in a research note on Monday, February 9th. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, Exponent currently has an average rating of “Moderate Buy” and a consensus target price of $90.00.

Get Our Latest Research Report on EXPO

Insider Buying and Selling at Exponent In related news, VP John Pye sold 4,000 shares of the firm’s stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $75.97, for a total value of $303,880.00. Following the completion of the transaction, the vice president owned 25,204 shares in the company, valued at $1,914,747.88. This trade represents a 13.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Catherine Corrigan sold 3,909 shares of the business’s stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $67.70, for a total value of $264,639.30. Following the sale, the chief executive officer owned 103,676 shares in the company, valued at approximately $7,018,865.20. The trade was a 3.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 15,741 shares of company stock valued at $1,095,768 over the last quarter. Insiders own 1.60% of the company’s stock.

Institutional Investors Weigh In On Exponent A number of institutional investors and hedge funds have recently modified their holdings of the company. United Services Automobile Association purchased a new position in Exponent during the 1st quarter worth approximately $270,000. Jane Street Group LLC increased its stake in shares of Exponent by 1,481.0% in the first quarter. Jane Street Group LLC now owns 127,222 shares of the business services provider’s stock worth $10,313,000 after acquiring an additional 119,175 shares during the period. Invesco Ltd. increased its stake in shares of Exponent by 3.3% in the second quarter. Invesco Ltd. now owns 554,733 shares of the business services provider’s stock worth $41,444,000 after acquiring an additional 17,930 shares during the period. First Trust Advisors LP purchased a new position in shares of Exponent during the second quarter worth $18,377,000. Finally, Walleye Capital LLC raised its holdings in shares of Exponent by 7.5% during the second quarter. Walleye Capital LLC now owns 6,623 shares of the business services provider’s stock worth $495,000 after purchasing an additional 464 shares during the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.

About Exponent (Get Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

Further Reading Five stocks we like better than Exponent

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEArrow Electronics (ARW) to Release Quarterly Earnings on Thursday

NEXT HEADLINE »Mohawk Industries (MHK) Projected to Post Earnings on Thursday
2026-06-12 13:47 4mo ago
2026-04-24 08:00 6mo ago
iQIYI Returns to LVL UP EXPO 2026 in Las Vegas with Blacklyte, Debuting Peter Pau AI Theater and Immersive AI Experiences
EXPO Exponent
FMP Stock News
Original source text
, /PRNewswire/ -- iQIYI International showcases AI-powered storytelling, Chinese anime, and VIP giveaways at the Las Vegas Convention Center on April 24–26, 2026, in partnership with premium Canadian immersive ecosystem brand, Blacklyte.

Founded in 2010, iQIYI (NASDAQ: IQ) is one of Asia's largest online entertainment platforms, and iQIYI International, launched in 2019, now serves over 100 million users across 190+ territories with a user interface and subtitles in 13 languages.

Characters from iQIYI and Blacklyte's collaborative projects, including The Great Ruler, In Search of God, and Embers. Experience the Future of AI Storytelling

At this year's LVL UP EXPO, iQIYI debuts the Peter Pau × iQIYI AI Theater, celebrating the Oscar-winning cinematographer of Crouching Tiger, Hidden Dragon.  Attendees will experience three AI-generated short films that demonstrate real-world applications of AI-driven storytelling and were completed with the assistance of iQIYI's proprietary AI technology and under the guidance of human creators and artists.

Day 1 - Celestial Quest: The first work from the AI Theater delivers sci-fi action as survivors fight back. Day 2 - Shrouded Hamet: A mysterious sound-transmitting stone binds the fates of two young girls. Day 3 - A tale of the snake-catcher: A decree to hunt snakes forces a human to transform into a giant serpent. "We are thrilled to return to LVL UP EXPO for our second consecutive year," said Mr. Leo Geng, Senior Vice President of iQIYI. "Our AI Theater offers a new way to experience storytelling, and thanks to our amazing partner Blacklyte, we can offer an immersive experience unlike anywhere else at the expo."

Global Success & 2026 Lineup

Following the global success of iQIYI's original Pursuit of Jade, iQIYI continues to demonstrate its ability to deliver high-performing content in international markets. iQIYI's 2026 original lineup features over 400 new titles, strengthening its content pipeline and long-term content supply. Highlights include fantasy romance Fate Chooses You starring Ren Jialun, and the highly anticipated romance drama Overdo starring Zhang Linghe and Wang Churan.

Visit the Blacklyte Booth co-presented with iQIYI for immersive AI Theater, VIP giveaways, free merch, and a photo booth.

Event Details: April 24–26, Las Vegas Convention Center, South Hall. Booth 317

Badges at https://lvlupexpo.com/ 

SOURCE iQIYI
2026-06-12 13:47 4mo ago
2026-04-25 04:02 6mo ago
Evergreen Capital Management LLC Takes $770,000 Position in Exponent, Inc. $EXPO
EXPO Exponent
FMP Stock News
Original source text
Posted by Defense World Staff on Apr 25th, 2026

Evergreen Capital Management LLC purchased a new stake in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 11,081 shares of the business services provider’s stock, valued at approximately $770,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. HM Payson & Co. increased its position in shares of Exponent by 33.9% during the 3rd quarter. HM Payson & Co. now owns 589 shares of the business services provider’s stock valued at $41,000 after purchasing an additional 149 shares during the last quarter. Arizona State Retirement System increased its position in shares of Exponent by 1.1% during the 3rd quarter. Arizona State Retirement System now owns 14,984 shares of the business services provider’s stock valued at $1,041,000 after purchasing an additional 162 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Exponent by 50.4% during the 4th quarter. GAMMA Investing LLC now owns 576 shares of the business services provider’s stock valued at $40,000 after purchasing an additional 193 shares during the last quarter. Hantz Financial Services Inc. increased its position in shares of Exponent by 97.0% during the 3rd quarter. Hantz Financial Services Inc. now owns 396 shares of the business services provider’s stock valued at $28,000 after purchasing an additional 195 shares during the last quarter. Finally, Orion Porfolio Solutions LLC increased its position in shares of Exponent by 2.6% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 8,525 shares of the business services provider’s stock valued at $637,000 after purchasing an additional 219 shares during the last quarter. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Exponent Price Performance Shares of EXPO opened at $65.88 on Friday. Exponent, Inc. has a 1 year low of $63.25 and a 1 year high of $81.95. The company has a 50 day simple moving average of $68.15 and a two-hundred day simple moving average of $70.27. The firm has a market cap of $3.20 billion, a P/E ratio of 31.67 and a beta of 0.80.

Exponent (NASDAQ:EXPO – Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The business services provider reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.02. Exponent had a net margin of 18.21% and a return on equity of 25.51%. The business had revenue of $147.43 million during the quarter, compared to analyst estimates of $128.48 million. During the same period last year, the firm posted $0.46 EPS. The company’s revenue was up 4.5% on a year-over-year basis. On average, sell-side analysts anticipate that Exponent, Inc. will post 2.27 earnings per share for the current year.

Exponent Increases Dividend The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Friday, March 6th were issued a dividend of $0.31 per share. This is an increase from Exponent’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, March 6th. This represents a $1.24 dividend on an annualized basis and a yield of 1.9%. Exponent’s payout ratio is 59.62%.

Analyst Upgrades and Downgrades EXPO has been the subject of several analyst reports. JPMorgan Chase & Co. reduced their target price on shares of Exponent from $100.00 to $95.00 and set an “overweight” rating for the company in a report on Thursday, March 26th. UBS Group reissued a “neutral” rating and issued a $85.00 target price on shares of Exponent in a report on Monday, February 9th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Exponent in a report on Tuesday. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $90.00.

View Our Latest Stock Report on Exponent

Insider Buying and Selling In other Exponent news, CEO Catherine Corrigan sold 3,909 shares of the stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of $67.70, for a total transaction of $264,639.30. Following the completion of the sale, the chief executive officer directly owned 103,676 shares of the company’s stock, valued at $7,018,865.20. This trade represents a 3.63% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP John Pye sold 4,000 shares of the stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $75.97, for a total transaction of $303,880.00. Following the sale, the vice president directly owned 25,204 shares of the company’s stock, valued at approximately $1,914,747.88. This trade represents a 13.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 15,741 shares of company stock valued at $1,095,768. Insiders own 1.60% of the company’s stock.

Exponent Company Profile (Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

See Also Five stocks we like better than Exponent Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEON Semiconductor Corporation $ON Shares Purchased by Evergreen Capital Management LLC

NEXT HEADLINE »Allison Transmission Holdings, Inc. $ALSN Shares Acquired by Caprock Group LLC
2026-06-12 13:47 4mo ago
2026-04-30 16:05 6mo ago
Exponent Declares Regular Quarterly Dividend for Q2 2026 and Increases Stock Repurchase Authorization by $50 Million
EXPO Exponent
FMP Stock News
Original source text
April 30, 2026 16:05 ET  | Source: Exponent, Inc.

MENLO PARK, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.31 per share of common stock to be paid on June 18, 2026 to all common stockholders of record as of June 5, 2026.

Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent’s Board of Directors.

In addition, Exponent’s Board of Directors increased the Company’s authority to repurchase shares of its common stock by $50 million. This is in addition to the $17.7 million available for repurchase as of April 3, 2026.

“Exponent’s quarterly cash dividend and increased share repurchase authorization reflects our continued commitment to returning capital to our shareholders,” commented Dr. Catherine Corrigan, President and Chief Executive Officer. “Supported by strong profitability and the strength of our balance sheet, we are well positioned to continue our disciplined capital allocation strategy and drive long-term value to shareholders.”

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.

Exponent may be reached at (888) 656­-EXPO, [email protected], or www.exponent.com.

Forward Looking Statements

This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.
2026-06-12 13:47 4mo ago
2026-04-30 16:05 6mo ago
Exponent Reports First Quarter 2026 Financial Results
EXPO Exponent
FMP Stock News
Original source text
MENLO PARK, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2026 ended April 3, 2026.

“Exponent delivered double-digit growth in revenues and earnings during the first quarter, reflecting the strength of our multidisciplinary portfolio and increased demand for our specialized expertise across industries,” stated Dr. Catherine Corrigan, President and Chief Executive Officer. “Growth was driven by proactive engagements, including user research studies for consumer electronics clients integrating AI into their devices, as well as risk management work for utility clients evaluating asset performance under extreme weather conditions. Reactive engagements also contributed to our growth, with increased dispute-related and failure analysis demand across construction projects, energy facilities, and medical devices.

“The integration of AI and other advanced technologies into physical products and performance-critical systems, combined with rising expectations for safety and reliability, is driving increased reliance on Exponent’s specialized expertise. At the same time, trends in energy demand, infrastructure risk, and innovation continue to support demand for our deep technical capabilities, reinforcing our essential role in helping clients navigate complex, high-stakes decisions,” Dr. Corrigan continued.

First Quarter Financial Results

Total revenues and revenues before reimbursements for the first quarter of 2026 increased 14% to $166.3 million and 10% to $151.8 million, respectively, as compared to $145.5 million and $137.4 million in the first quarter of 2025.

Net income increased to $29.6 million, or $0.59 per diluted share, in the first quarter of 2026, as compared to $26.7 million, or $0.52 per diluted share, in the same period of 2025. During the quarter, Exponent realized a negative tax impact associated with share-based awards of $0.9 million as compared to $0.5 million in the first quarter of 2025. Inclusive of the negative tax impact, Exponent's consolidated tax rate was 30.2% in the first quarter, as compared to 29.4% for the same period in 2025.

EBITDA1 increased to $43.1 million, or 28.4% of net revenues, in the first quarter of 2026, as compared to $37.5 million, or 27.3% of net revenues in the first quarter of 2025.

During the first quarter of 2026, Exponent paid $16.6 million in dividends, repurchased $78.8 million of common stock, and closed the period with $118.6 million in cash and cash equivalents.

In a separate press release today, Exponent announced its quarterly cash dividend of $0.31 to be paid on June 18, 2026, and reiterated its intent to continue to pay quarterly dividends. Additionally, Exponent’s Board of Directors approved an increase in the current stock repurchase program of $50 million. This is in addition to the $17.7 million available for repurchases as of April 3, 2026. 

Business Overview

Exponent’s engineering and other scientific segment represented 85% of the Company’s revenues before reimbursements in the first quarter of 2026. Revenues before reimbursements in this segment increased 12% in the first quarter, compared to the prior year period. Growth during the quarter was driven by user research studies in consumer electronics and risk management in the utilities sector, along with reactive engagements in the energy and life sciences sectors.

Exponent’s environmental and health segment represented 15% of the Company’s revenues before reimbursements in the first quarter. Revenues before reimbursements in this segment increased 2% in the first quarter, compared to the prior year period. Growth in this segment was primarily driven by Exponent’s regulatory consulting in the chemical industry.

Business Outlook

“Exponent delivered a strong first quarter, with 5% year-over-year headcount growth, 76% utilization, and strong rate realization driving growth,” commented Richard Schlenker, Executive Vice President and Chief Financial Officer. “We are encouraged by the market opportunities and remain confident in the long-term growth trajectory of the business.”

For the second quarter of fiscal 2026 as compared to the same period one year prior, Exponent anticipates:

Revenues before reimbursements to grow in the high-single digits; and,EBITDA1 to be 27.0% to 27.8% of revenues before reimbursements. For the full fiscal year 2026 as compared to fiscal year 2025, Exponent is maintaining its guidance and anticipates:

Revenues before reimbursements to grow in the high-single digits; and,EBITDA1 to be 27.6% to 28.1% of revenues before reimbursements. “Exponent is well positioned to support the evolving needs of our clients as innovation accelerates and systems grow more complex, particularly as AI is increasingly embedded in the physical world,” Dr. Corrigan said. “These dynamics continue to drive demand for our differentiated multidisciplinary expertise, independent evaluation, and trusted insight.

“Our recent leadership evolution further strengthens our ability to capitalize on these opportunities,” Dr. Corrigan continued. John Pye brings visionary leadership and a proven track record of innovation, playing a key role in advancing our capabilities while remaining firmly grounded in the technical rigor and independence that define Exponent. Eric Anderson adds deep financial and operational expertise, along with a strong understanding of our business and strategy. Rich Schlenker will continue to serve as Executive Vice President and has been nominated for election to the Board of Directors. Supported by our exceptional talent and distinct position in the marketplace, Exponent is well positioned to build on our momentum and deliver long-term value for our clients and shareholders.”

Today's Conference Call Information

Exponent will discuss its financial results in more detail on a conference call today, Thursday, April 30, 2026, starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. The audio of the conference call is available by dialing (844) 481-2781 or (412) 317-0672. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent website, or by dialing (855) 669-9658 or (412) 317-0088 and entering passcode 4146822#.

Use of non-GAAP Financial Measures 1

EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation, and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income, and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present, and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position, or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.

Exponent has provided its outlook regarding EBITDA as a percentage of revenues before reimbursements. The Company has not reconciled this non-GAAP financial measure to the corresponding GAAP financial measure because guidance for the various reconciling items is not provided and the Company is unable to estimate with reasonable certainty the effect of these items without unreasonable effort. For example, the Company is unable to estimate with reasonable certainty the impact of equity awards on Exponent’s taxes without unreasonable effort. These items are uncertain, depend on various factors, and may have a material effect on Exponent’s results computed in accordance with GAAP. A reconciliation between the historical GAAP and non-GAAP financial measures presented in this release is provided in the financial tables at the end of this release.

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent's consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent's offices in North America, Asia, and Europe. Exponent's consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.

Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.

Forward Looking Statements

This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

Source: Exponent, Inc.

EXPONENT, INC.CONDENSED CONSOLIDATED STATEMENTS OF INCOMEFor the Quarters Ended April 3, 2026 and April 4, 2025(unaudited)(in thousands, except per share data)       Quarters Ended April 3, April 4, 2026
 2025
    Revenues   Revenues before reimbursements
$151,817  $137,437 Reimbursements
 14,486   8,070     Revenues
 166,303   145,507     Operating expenses   Compensation and related expenses
 91,409   75,903 Other operating expenses
 12,825   12,095 Reimbursable expenses
 14,486   8,070 General and administrative expenses
 6,204   5,007     Total operating expenses
 124,924   101,075     Operating income
 41,379   44,432     Other income   Interest income, net
 1,718   2,714 Miscellaneous income (expense), net
 (758)  (9,386)  960   (6,672)    Income before income taxes
 42,339   37,760     Income taxes 12,770   11,110         Net income
$29,569  $26,650         Net income per share:   Basic
$0.59  $0.52 Diluted
$0.59  $0.52     Shares used in per share computations:   Basic
 49,790   51,283 Diluted
 50,119   51,650      EXPONENT, INC.CONDENSED CONSOLIDATED BALANCE SHEETSApril 3, 2026 and January 2, 2026(unaudited)(in thousands)         April 3, January 2, 2026
 2026
Assets   Current assets:   Cash and cash equivalents
$118,553  $221,930 Accounts receivable, net
 197,336   181,507 Prepaid expenses and other assets
 24,999   24,143 Total current assets
 340,888   427,580 Property, equipment and leasehold improvements, net 71,875   71,981 Operating lease right-of-use asset 70,451   73,376 Goodwill 8,607   8,607 Other assets 195,560   195,975 Total assets
$687,381  $777,519     Liabilities and Stockholders' Equity   Current liabilities:   Accounts payable and accrued liabilities
$37,354  $30,942 Accrued payroll and employee benefits
 82,561   121,302 Deferred revenues
 15,568   18,868 Operating lease liability
 6,715   6,890 Total current liabilities
 142,198   178,002 Other liabilities 132,523   133,232 Operating lease liability 74,323   75,944 Total liabilities
 349,044   387,178     Stockholders' equity:   Common stock
 66   66 Additional paid-in capital
 386,329   369,747 Accumulated other comprehensive loss
 (2,571)  (2,290)Retained earnings
 682,013   668,423 Treasury stock, at cost
 (727,500)  (645,605)Total stockholders' equity
 338,337   390,341 Total liabilities & stockholders' equity
$687,381  $777,519      EXPONENT, INC. EBITDA and EBITDAS (1) For the Quarters Ended April 3, 2026 and April 4, 2025(unaudited)(in thousands)         Quarters Ended  April 3, April 4,  2026
 2025
      Net Income$29,569  $26,650       Add back (subtract):         Income taxes
 12,770   11,110  Interest income, net
 (1,718)  (2,714) Depreciation and amortization
 2,515   2,492       EBITDA (1)
 43,136   37,538       Stock-based compensation
 9,058   8,179       EBITDAS (1)
$52,194  $45,717                 (1) EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.
2026-06-12 13:47 4mo ago
2026-04-30 19:26 6mo ago
Exponent (EXPO) Surpasses Q1 Earnings and Revenue Estimates
EXPO Exponent
FMP Stock News
Original source text
Exponent (EXPO - Free Report) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.52 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +5.36%. A quarter ago, it was expected that this engineering and scientific consulting company would post earnings of $0.47 per share when it actually produced earnings of $0.49, delivering a surprise of +4.26%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Exponent, which belongs to the Zacks Consulting Services industry, posted revenues of $151.82 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 3.40%. This compares to year-ago revenues of $137.44 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Exponent shares have lost about 4.7% since the beginning of the year versus the S&P 500's gain of 4.2%.

What's Next for Exponent?While Exponent has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Exponent was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.57 on $142.6 million in revenues for the coming quarter and $2.27 on $581.31 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Consulting Services is currently in the top 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Hackett Group (HCKT - Free Report) , is yet to report results for the quarter ended March 2026. The results are expected to be released on May 5.

This consulting company is expected to post quarterly earnings of $0.35 per share in its upcoming report, which represents a year-over-year change of -14.6%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Hackett Group's revenues are expected to be $71.65 million, down 6% from the year-ago quarter.
2026-06-12 13:47 4mo ago
2026-05-01 04:51 6mo ago
Exponent, Inc. (EXPO) Q1 2026 Earnings Call Transcript
EXPO Exponent
FMP Stock News
Original source text
Exponent, Inc. (EXPO) Q1 2026 Earnings Call Transcript
2026-06-12 13:47 4mo ago
2026-05-04 07:25 5mo ago
Exponent: Rising Demand And A Reasonable Valuation Make It A Buy
EXPO Exponent
FMP Stock News
Original source text
Exponent is a market leader in scientific and engineering consulting, boasting a 13-year dividend growth streak and a fortress balance sheet. EXPO's fiscal 2026 outlook signals rising top and bottom lines, with AI-related demand driving proactive and reactive service growth. The stock trades at ~26.5x FY26E EPS, well below its 5-year average, suggesting undervaluation with a fair value estimate of $73.80 versus a ~$65 share price.
2026-06-12 13:47 4mo ago
2026-06-05 16:05 4mo ago
Exponent to Participate in a Fireside Chat at the Wells Fargo 16th Annual Industrials & Materials Conference
EXPO Exponent
FMP Stock News
Original source text
June 05, 2026 16:05 ET  | Source: Exponent, Inc.

MENLO PARK, Calif., June 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson will participate in a fireside chat at the following investor conference:

Wells Fargo 16th Annual Industrials & Materials Conference

Date: Tuesday, June 9, 2026Time: 12:00 p.m. Eastern Time / 9:00 a.m. Pacific Time
A webcast of the presentation will be accessible on the investor relations section of the Exponent website, http://www.exponent.com/investors. An archived replay of the webcast will be available following the live event. 

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent's consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent's offices in North America, Asia, and Europe. Exponent's consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.

Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.